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Abstract
Substituted benzenoid rings are a prevalent motif in many industries
including high tech, agrochemicals, and pharmaceuticals. As a result, the arylation
of chemical compounds is a highly sought-after chemical transformation. There
are many literature methods to achieve this chemical transformation, nucleophilic
aromatic substitution and transition metal catalysis are both widely used and
studied. Diaryliodonium salt mediated chemistry is an attractive alternative to
these methods as it does not require the expensive toxic metals and designer
ligands of transition metal catalysis and is not restricted to electron deficient aryl
rings with specific substitution patterns like nucleophilic aromatic substitution.
Many diaryliodonium salt arylation reactions rely upon symmetric
diaryliodonium salts that are difficult to synthesize and have poor atom economy
and are undesirable for complex aryl groups. I have developed synthetic pathways
to form diaryl and alkyl-aryl ether molecules that are high yielding and functional
group tolerant using easy to manufacture unsymmetric aryl(TMP) iodonium
tosylate salts. These reactions are operated at low temperatures under mild
conditions and allow for many different functional groups, substitution patterns
and electronic effects on the aryl group. Electron rich aryl groups are not
prominent in the diaryliodonium salt literature especially in alkyl-aryl ether
synthesis, the synthetic routes I developed show competitive yields with a variety
of electron rich aryl groups, expanding the scope of this chemistry.

i

I have also developed an efficient high yielding methodology for counter
anion metathesis of diaryliodonium salts using solid state columns of exchange
salt made from common laboratory supplies. Literature reactions are highly
inefficient and use vast excess of exchange salt; the chemistry I developed allows
for the reuse of exchange salt for more economic and efficient counter anion
metathesis.
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1. Introduction
1.1 Importance of Substituted Aromatic Molecules
Aromatic rings are a very common moiety in agrochemicals, novel materials,
and pharmaceuticals, greater than 90% of the top 200 small molecule
pharmaceutical drugs in the United States in 2020 contained substituted aromatic
rings.1 Functionalizing aromatic rings to form new carbon-carbon and carbonheteroatom bonds is an important part of organic synthesis and the development
of new methodology to form these bonds is highly desirable. Aromatic rings
substituted with ethers are also highly present in many desirable synthetic targets;
of the top 200 small molecule drugs in 2020 15% of them contained aromatic
ethers.1 Figure 1 demonstrates the top 3 examples of aromatic ether
pharmaceuticals with a total sale of 27.6 billion dollars in the United States in
2020.

Figure 1. Pharmaceutical molecules containing ether bonds
1

1.2 Literature Synthesis of Substituted Aromatic Rings
A common synthetic pathway to achieve this moiety is by reacting an aryl
electrophile bearing a leaving group with a nucleophile. Aryl (pseudo)halides are
well known in both metal free2 and metal catalyzed arylation reactions.3 Some of
the most commonly known and used reactions of this type are: electrophilic
aromatic substitution, nucleophilic aromatic substitution, aryne formation and
transition metal catalysis. (Figure 2)

Figure 2. Synthesis of substituted aromatic rings
Electrophilic aromatic substitution (SEAr) utilizes an electron rich
aromatic ring as a nucleophile to couple with an electrophile (E). During
nucleophilic aromatic substitution (SNAr) a nucleophile will react with an electron
2

poor aromatic ring and replace a (pseudo)halide. Aryne formation requires a
leaving group (often a (pseudo)halide) on the ring to form a highly reactive aryne
triple bond that can then react at either of the two aryne carbons with
nucleophiles. Transition metal catalysis reactions make use of a transition metals
ability to form multiple bonds and change oxidation states to couple an aromatic
ring bearing a (pseudo)halide with a nucleophile.
1.2.1 Electrophilic Aromatic Substitution of Substituted Aromatic Rings
SEAr was discovered in the 19th century and has since been studied
extensively and utilized for many industrial processes and synthesis. This reaction
requires the aromatic ring to function as a nucleophile and the coupling partner to
act as the electrophile. This reaction proceeds through a two-stage process via a π
and a σ complex as demonstrated in Figure 3.4

Figure 3. Electrophilic aromatic substitution mechanism
The electronic character of the ring substituents has a strong effect on the
substitution pattern of the resulting products. Electron donating groups (alkyl,
ether, amine, and alcohol) and poor electron withdrawing groups (halogens) direct
the reaction to the ortho and para positions while highly electron withdrawing
3

groups (nitro, ketone, cyano, ammonia) direct the reaction to the meta position. A
wide variety of substituents can be introduced using this chemistry including:
acyl, halo, nitro and sulfo.5
1.2.2 Nucleophilic Aromatic Substitution of Substituted Aromatic Rings
SNAr is another widely studied and used methodology to access
substituted aromatic compounds.6 This methodology is complementary to
electrophilic aromatic substitution in that the aromatic group acts as the
electrophile and the coupling partner acts as the nucleophile. The nucleophile
coupling partner will displace a leaving group (usually a halide) on the aromatic
ring via a Meisenheimer complex as shown in Figure 4.

Figure 4. Nucleophilic aromatic substitution mechanism
This reaction is limited by the necessity of strong electron withdrawing
groups (nitro, cyano, etc..) ortho or para to the leaving group to stabilize the
Meisenheimer complex, and as such the scope of possible aryl groups that this
reaction will tolerate is quite low.
1.2.3 Aryne Mediated Synthesis of Substituted Aromatic Rings
An alternate pathway to nucleophilic substitution on an aromatic ring is
via the generation of aryne intermediates by using a strong base on
4

(pseudo)halogenated arenes. The resulting aryne is highly reactive and can be
used to form many different substituted arene products but aryne reactions do
have the potential to form regioisomers as they can react at either end of the
resulting carbon-carbon triple bond as demonstrated in Figure 5.

Figure 5. Aryne reaction mechanism
1.2.4 Transition Metal Catalyzed Synthesis of Substituted Aromatic Rings
The functionalization of aryl (pseudo)halides facilitated by transition
metals has been extensively studied and utilized in recent years; especially
reactions featuring palladium catalysis which won the Nobel Prize in chemistry in
2010.7,8 This approach greatly increases the scope of possible synthetic products
available including carbon-carbon and carbon heteroatom bonds that were
previously challenging.9 The main reason for this expanded scope is that in
transition metal catalyzed reactions a significant charge formation does not build
up on the ring as in SEAr and SNAr. This reaction proceeds through a three-step
process: first an oxidative addition of an aryl (pseudo)halide to a transition metal,
followed by a transmetalation of the desired nucleophile (Nu) coupling partner to
the metal complex, then a reductive elimination to extrude the final product. This
process also regenerates the starting catalyst which allows for multiple turnovers
5

of a single catalyst molecule forming many product molecules as demonstrated in
Figure 6.

Figure 6. Mechanism of a metal catalyzed cross coupling reaction
Metal catalyzed cross coupling is a versatile and powerful tool but there
are challenges to using it. These challenges include the high cost of metal
catalysts and designer ligands as well as the difficult process of removing the
residual toxic metals from the end product. A wide range of metal free arylation
methods have been investigated as an attempt to avoid these issues. 10 In order for
a method to be considered a viable alternative to transition metal catalysis it
should have mild reaction conditions that tolerate a wide range of functional
groups as well as be economically efficient.

6

1.3 Hypervalent Iodine Compounds
Hypervalent iodine compounds have been extensively researched in recent
years as novel reagents in oxidation, aryne formation, and ispo substitution
reactions.11 There are two main categories of synthetically useful iodonium
reagents: trivalent hypervalent iodine (III) or λ 3 iodanes under IUPAC
nomenclature, and pentavalent hypervalent iodine (V) or λ 5 iodanes reagents.12
Hypervalent iodine (III) compounds featuring two aryl groups are called
diaryliodonium salts and are often used as arylating reagents. Hypervalent iodine
(V) compounds are often used as oxidizing agents, especially Dess-Martin
Periodane (DMP) and 2-iodoxybenzoic acid (IBX).13
Diaryliodonium salts have been shown to have many applications in the
field of organic synthesis. The field was explored in 1953 by Berringer who
published the reactivity of diphenyliodonium bromide. 14 These reagents have
been shown to react in metal free conditions with a variety of different carbon and
heteroatom nucleophiles including: alkyl Grignard reagents, 15 enolates,16 as well
as nitrogen,17 oxygen,18–20 and fluorine21 nucleophiles.
There are many mechanistic parallels between metal catalysis cross
coupling reactions and diaryl iodonium salt cross coupling reactions. The two
reactions have the same 3 major components: an oxidative addition, a ligand
exchange (often transmetalation for metal catalysis) and then a reductive
elimination to form the desired product. In the case of the diaryl iodonium salts

7

the oxidative step occurs during the synthesis of the salt as demonstrated in Figure
7.

Figure 7. General reactivity of diaryl iodonium salts
Diaryliodonium salts demonstrate some of the best qualities of both metal
catalyzed reaction and SNAr. They maintain the broad scope of transition metal
catalysis due to their similar reaction mechanisms as well as the operational
simplicity of SNAr. They also do not require metal remediation steps or require
designer ligands.
1.3.1 Structure and Synthesis of Diaryliodonium Salts
Diaryliodonium salts are a form of λ3 iodane bearing 2 aryl rings and a
counter anion; they are air and moisture stable, react under mild conditions and
are easily synthesized from aryl iodides.22 These compounds have seen wide use
as arylation agents; reacting via ipso substitution and aryne reaction pathways to
generate substituted arene compounds.
Diaryliodonium salts contain 2 aryl rings and counter anion that are
orthogonally positioned at ~90o angles giving the molecule a T shape geometry,
or pseudo trigonal bipyramidal geometry when the electron groups are considered
8

as show in Figure 8. The most commonly employed aryl auxiliaries (Aryl) are
1,3,5-trimethoxy phenyl and mesitylene, the most commonly used counter anions
(X) are OTs, OTf, BF4, Br and PF6.

Figure 8. Structure of a diaryliodonium salt
Diaryliodonium Salts fall primarily into two categories, symmetric
diaryliodonium salts and unsymmetric diaryliodonium salts. In symmetric
diaryliodonium salts the two aryl groups are the same, in unsymmetric
diaryliodonium salts the two aryl groups are different as shown in Figure 9.

Figure 9. Symmetric and unsymmetric diaryliodonium salts
These diaryliodonium salts have been synthesized by a variety of means;
typically beginning with the oxidation of an aryl iodide or molecular iodide in the
9

presence of a simple arene, followed by a ligand exchange with an addition arene
to yield the diaryliodonium product. There are also synthesis developed that
originate with an aryl boronic acid goes on to become one of the aryl groups in
the resulting diaryliodonium salt.
The primary methodology employed to synthesize these salts is to oxidize
an aryl iodide to the corresponding iodine (III) compound followed by a ligand
exchange with a simple arene or organometallic reagent. This reaction is typically
carried out in acidic conditions and the conjugate base of the acid used becomes
the counter anion of the resulting diaryliodonium salt as shown in Figure 10. The
most commonly employed acids are p-toluenesulfonic acid (TsOH) and
trifluoromethane sulfonic acid (TfOH). This route allows for the synthesis of both
symmetric and unsymmetric diaryliodonium salts and the products of this reaction
can be isolated without the use of column chromatography. 22–25

Figure 10. Synthesis of diaryliodonium salt from aryl iodide
These salts can also be synthesized from aryl boric acids as was first
report by Ochiai et all in 1996.26 This method utilizes pre oxidized hypervalent
diacetoxyiodoarenes and alkali metal tetraarylborates to form diaryliodonium salts
in high yields. The reaction was later improved upon to tolerate aryl boronic acids
10

in the presence of a strong Lewis acid, such as boron trifluoride or boron
trifluoride etherate as shown in Figure 11. 27

Figure 11. Synthesis of diaryliodonium salts from boronic acids
Diaryliodonium salts can also be synthesized from simple arenes and
molecular iodide or hypervalent diacetoxyiodoarenes. When using molecular
iodine the reaction is nearly identical to the reaction from iodoarenes, except the
iodoarene is formed in-situ during the oxidation step. This method is severely
limited in the scope of possible products as it can only make symmetric salts and
is limited to a few groups such as: tert butyl benzene, halobenzene and benzene. 28

11

Figure 12. Synthesis of diaryliodonium salts from simple arenes
There is also a variation of Ochiai’s methodology that uses simple arene
instead of boronic acid and diacetoxyarene that can be used to synthesize
unsymmetrical diaryliodonium salts.29
1.3.2 Synthetic Advantages of Unsymmetric Diaryl Iodonium Salts
This work focuses on the synthesis of substituted aromatic rings via
diaryliodonium salts, which has been previously documented in the literature. The
majority of the examples of this chemistry have been demonstrated using
symmetric diaryliodonium salts.18,19,30,31 While symmetric diaryliodonium salts
have the advantage of guaranteeing the desired aryl coupling partner they do have
two main disadvantages compared to unsymmetric diaryliodonium salts. The first
of which is that symmetrical diaryliodonium salts produce a stoichiometric
quantity of aryl iodide side product during cross coupling reactions. While using a
simple aryl group this does not pose much of a problem, but when using a
12

complex aryl group this results in a large portion of the starting material being
wasted as demonstrated in Figure 13.

Figure 13. General reactivity of symmetric vs unsymmetric diaryliodonium salts
The second main drawback of symmetric diaryliodonium salts is the
difficulty of synthesizing complex symmetric diaryliodonium salts, as well as the
commercial availability of the starting materials. Most unsymmetric diaryl
iodonium salts can be made from an aryl iodide and a simple arene auxiliary
including the two most commonly used auxiliaries TMP and Mes. 22 Whereas
symmetric diaryliodonium salts can only be made from simple arenes in specific

13

substitution patterns and usually require an aryl iodide and an identical aryl
boronic acid in order to make the symmetric salt.
Unsymmetrical diaryliodonium reagents do possess some limitations.
The main limitation is that in order for an auxiliary aryl group to function as an
auxiliary it must be significantly more electron rich than the desired coupling
partner in order to achieve the desired selectivity and products as demonstrated in
Figure 14.

Figure 14. Proposed mechanism of diaryliodonium salt ipso substitution
Once the ligand exchange of the nucleophile for the counter anion X
occurs the resulting three membered complex (B and C) is formed as shown in
Figure 14. It will then undergo a Berry pseudo rotation-like process equilibrating
between B and C. Of the two possible transition states the top one is preferred due
to the electron deficient character of the aryl ring that has the buildup of partial
negative charge, stabilizing said charge. The bottom structure is unfavored due to
14

the electron rich character of the ring with the electron donating substituents
destabilizing the partial negative charge buildup that occurs. The molecules then
undergo reductive elimination to produce the two products, an aryl iodide and the
aryl nucleophile coupling product. If a highly electron rich auxiliary aryl group
such as TMP or Mes is used then the desired coupling partner is exclusively
formed and the aryl auxiliary is extruded as aryl iodide.
Due to these considerations in this work unsymmetrical diaryliodonium
salts were the main focus of our synthetic investigations. These salts are easier to
synthesize, have better atom economy and a wider range of possible starting
materials than the symmetric salts.

15

2. Synthesis of Diaryl Ethers via Unsymmetric aryl(TMB)iodonium Tosylate
Salts.
This work was previously published as:
Gallagher, R. T.; Basu, S.’ Stuart, D. R. Trimethoxyphenyl (TMP) as a Useful
Auxiliary for in-situ Formation and Reaction of Aryl(TMP)iodonium Salts:
Synthesis of Diaryl Ethers Adv. Synth. Catal. 2020, 362, 320-325.32
Author contribution:
This project is a continuation of work devised by Dr. David R. Stuart and Dr.
Sunil K. Sundalam.33 Dr. David R. Stuart and I conceived of this project based on
work done by Dr. Sunil K. Sundalam. I performed all optimization studies for this
project including analysis of mild bases, final optimization and optimization of
telescoped reaction conditions. While I isolated many of the products in the scope
table Dr. Basu isolated the more challenging and complex substrates including
biologically active molecule 14m and 14k. I have written this chapter for my
thesis. The majority of the isolated compounds were characterized by me and
some of them were characterized by Dr. Basu. HRMS data was collected with the
assistance of Dr. Aleksandra Nilova, Dr. Karley Maier and Dario Durastani. I
compiled the majority of the supporting information for the previously published
paper with assistance from Dr. Basu.
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Figure 15. Synthesis of diaryl ethers from aryl iodides via the in-situ formation of
diaryliodonium salts
This work demonstrates the synthesis of diaryl ethers from aryl iodides via
the in-situ formation of diaryliodonium salts. This reaction is facilitated by the use
of 1,3,5-trimethoxyphenyl (TMP) as a “dummy” auxiliary ligand to facilitate the
transfer of a wide range of aryl moieties to a variety of phenols. This work
expands upon the scope of available coupling partners especially electron rich
aryl moieties as well as explore the synthesis of desired but previously unreported
highly sterically hindered diaryl ether compounds. By forming the diaryliodonium
salts in-situ the limitation of a separate synthesis and isolation is avoided and
allows for the use of readily available and abundant aryl iodides as starting
materials.
2.1 Literature Metal Catalyzed Arylation of Phenol Nucleophiles
Diaryl ethers can be synthesized via a variety of methods including classic
copper based Ullman coupling using aryl iodides and phenols. This method
requires stoichiometric copper and harsh conditions. 34 The development of
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catalytic reactions have allayed some of these issues however these reactions
often require excess of reagents, high temperatures, long times, and high catalyst
loading.35–37 The related palladium catalyzed C-O coupling was pioneered by
Buchwald and co-workers via phenols and aryl (pseudo)halides in 1999. 38

Figure 16. Classic Ullman coupling and palladium catalysis to form diaryl ethers
While these reactions are very effective and efficient, they are not without
their drawbacks. The high cost and environmental problems that arise from using
expensive toxic metals make transition metal free reactions that do not require
expensive metals or large-scale processes to remove residual metals very
desirable.
2.2 Literature Arylation of Phenol Nucleophiles via Diaryliodonium Salts
Ether synthesis via diaryliodonium salts has been previously reported via
both metal catalyzed and metal free methods. Metal catalyzed reactions are rarer
but have been reported in recent years. Copper catalysis was employed to
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synthesize β-aryloxy carbonyl compound under relatively mild conditions in
2014.39 Copper catalysis was also used to arylate carboxylic acids with
diaryliodonium salts in 2015.40 (Figure 17)

Figure 17. Metal catalyzed arylation of oxygen nucleophiles (enolates top,
carboxylic acids bottom)
Metal free oxygen arylation via diaryliodonium salts has been widely
reported, especially in the last 15 years. Olofsson and co-workers have reported
multiple metal free synthesis of diaryl ethers from mostly symmetric
diaryliodonium salts in 2011 and 2013.19,31 Togo and co-workers reported a
synthesis of diaryl ethers via unsymmetric diaryliodonium salts in 2013. 41 Gaunt
and co-workers published a counter anion triggered diaryl ether synthesis via
diaryliodonium fluorides in 2015.42 (Figure 18)

19

Figure 18. Metal free diaryl ether synthesis via diaryliodonium salts
These literature reactions generally require harsh bases (tert-butoxide or
hydride) and have limited reactivity with electron rich aryl groups. Many of them
rely on symmetric diaryliodonium salts which produce stoichiometric aryl iodide
waste and are prohibitive for the synthesis of large, complex aryl groups.
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Another drawback of these reactions that is often cited by reviewers is that
the synthesis and isolation of the diaryliodonium salts adds to the complexity of
the overall synthesis. Synthesizing the diaryliodonium salts in-situ would remove
the need for a separate synthetic step and allay these concerns. 43–45 In this work
we addressed this issue by synthesizing diaryl ethers from various substituted
phenols and diaryliodonium reagents as well as from aryl iodides by forming the
diaryliodonium salts in-situ.
2.3 Optimization of the Reaction
The majority of previous methodologies to synthesize diaryl ethers via
diaryliodonium salts relied upon harsh bases or symmetric diaryliodonium salts
both of which place constraints upon the scope of possible aryl groups and
phenols that would be tolerated in the reaction, especially electron rich aryl
groups.18,19,31,33,42 Our goal was to develop a synthetic methodology using
unsymmetric diaryliodonium salts and mild base to avoid these issues.
We decided to use the TMP auxiliary ligand for our unsymmetric
diaryliodonium salts. This use of this ligand allows for easy one pot synthesis to
the two most commonly used counter anions tosylate and triflate as well as total
selectivity for the desired aryl coupling partner even when using highly electron
rich aryl groups.22,23 Once we had arrived upon this auxiliary we then investigated
a wide range of weak bases and counter anions to determine if a weak base could
facilitate the desired cross coupling reaction using the tolyl aryl group and phenol
as our model substrate. We chose this model system due to the difficulty of
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synthesizing diaryl ethers from electron rich aryl groups in previous methods and
wanted to ensure that our methodology could tolerate electron rich aryl groups.
When using harsh bases such as sodium hydride or tert-butoxide this
reaction requires a prestir step, in which the base deprotonates the phenol before
the diaryliodonium salt is added. This ensures that the active species is a
phenoxide during the reaction. The reaction of phenoxides and diaryliodonium
salts has been studied several times in the past including by Berringer in 1955 as
well as our own group more recently by Dr. Basu. 46 In contrast to this when using
potassium carbonate the pKa of phenol is 29.5 substantially higher than the pKa
of bicarbonate (the conjugate acid of carbonate) is only 10.3 meaning that hardly
any of the phenol should be deprotonated in solution.
The tosylate counter anion and potassium carbonate showed excellent
(>80%) reactivity with phenol and so we settled on that as our model system and
tested a wide range of parameters including: time, temperature, a wide range of
possible bases and counter anions, symmetric diaryliodonium salts, equivalents of
reagents, and solvents. The ideal conditions found during this optimization
showed 99% NMR yield for the model system as shown in Figure 19. These
conditions are 1.1 equivalents of phenol, 3 equivalents of potassium carbonate as
base, toluene as a solvent with 0.2 molar concentration of diaryliodonium salt, at
55 °C and, a 2-hour reaction time.
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Entry

Deviation from standard conditions

NMR Yield

1

none

99%

2

76%

3

[di-(4-tolyl)]iodoniumtosylate instead
of TMB salt
OTf as counter anion of OTs

94%

4

BF4 as counter anion of OTs

70%

5

1 equiv. of K2CO3

88%

6

KOt-Bu instead of K2CO3

79%

7

NaHCO3/TBAF instead of K2CO3

29%

8

NaOH instead of K2CO3

97%

9

THF instead of toluene

93%

10

MeCN instead of toluene

85%

11

80 °C as reaction temp.

96%

12

21 °C as reaction temp, 24-hour
reaction time

25%

Figure 19. Optimization of diaryl ether synthesis via diaryliodonium salts
This optimization demonstrates that the reaction proceeds at a low
temperature under mild conditions. When using the symmetric salt which is
substantially more difficult to synthesize the yield dropped by over 20%. (entry 2)
This highlights trimethoxy benzenes utility as an auxiliary ligand. This reaction
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also results in a 20% lower yield when using harsh bases such as sodium tertbutoxide, sodium hydride was also tested and observed a similarly lower yield.
(entry 6) The reaction does display a temperature dependence; the yield drops
substantially at temperatures lower than thirty-five °C (entry 12) and at
temperatures above 80 °C (entry 11). The reaction also tolerates a wide range of
solvents ranging from non-polar (toluene) to highly polar (acetonitrile) (entries 910).
2.4 Scope of the Reaction
The scope of both phenols and aryl groups was investigated under the
standard conditions of the reaction as shown in Figure 20 and Figure 21. The
reaction tolerates a wide range of electronic effects and functional groups
including highly electron rich and polysubstituted aryl moieties.
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Figure 20. Diaryl ether synthesis scope for iodonium salts
This reaction demonstrates an average yield of 82% over 16 different aryl
groups. The reaction also shows high yields for ortho, meta and para substituted
arenes as demonstrated by para-,meta-,ortho-tolyl (1-3) and para-,meta-,orthochloro (4-6) which highlights the wide range of possible steric and electronic
effects that are tolerated by this reaction. A large variety of other electron
donating and electron withdrawing aryl groups are also tolerated. The reaction
also demonstrates great results for a wide range of electronic effects ranging from
highly electron rich aryl moieties (9-10) to very electron deficient aryl groups (11,
15). The reaction also demonstrates preferential transfer for even highly electron
rich aryl components over 1,3,5-trimethoxy benzene as shown by compound 9
being synthesized in 85% yield while no arylated 1,3,5-trimethoxy benzene was
observed.
This reaction is also very useful for transferring elaborate poly substituted
aryl groups (14-16), a reaction that symmetric diaryliodonium salts would be very
difficult to synthesize and result in stoichiometric waste. This reaction is also very
useful for transferring highly sterically congested aryl groups (16) and
heterocyclic aryl groups (13). The results of this study were compared to literature
results for other synthesis using diaryliodonium salts and were found to be
comparable or superior to the literature methods.18,19,31,47,48
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Figure 21. Diaryl ether synthesis scope for phenols
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The aryl(TMP)tosylate para methyl ester was chosen as the model
substrate to test the scope of possible phenols for this reaction. The scope of
phenol coupling partners also displays a wide range of tolerated steric and
electronic effects, with an average of 83% yield over 14 substrates including large
biologically active molecules. Electronic effects of the phenol are also widely
tolerated from the electron rich ortho-tolyl (17) and ortho,ortho di tolyl (22) to the
electron deficient meta-cyano (20) and para-aldehyde (26). This reaction also
tolerates aldehyde functionalized phenols (26) as well as N-H bonds (28) which
prove challenging under other synthetic pathways. This reaction also supports
polysubstituted phenols as well as aryl halide substituted phenols (23) which can
allow for further product functionalization and are not tolerated under metal
catalyzed reactions. The reaction also shows high yields for highly sterically
encumbered phenols (22) which was observed in 82% yield. The reactions can
also be used to couple large complex biologically active phenols such as esterone
(30) and α-tocopherol (29) in moderate yields of 68% and 61% respectively.
Overall the reaction displays a robust scope that tolerates a wide range of
electronic and steric effects, many different functional groups some of which are
challenging under other synthetic pathways and large biologically active
molecules in good yield.
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2.5 One Pot Telescoped Synthesis of Diaryl Ethers from Aryl Iodides
In order to further the development of diaryliodonium salt chemistry as a
viable alternative to metal catalysis we developed a method to telescope (perform
sequentially in one pot) the three reactions required for the synthesis of diaryl
ethers from diaryl iodides: 1) the oxidation of an aryl iodide into a λ-3 iodane, 2)
the ligand exchange of that λ-3 iodane with an aryl group to form a
diaryliodonium salt and 3) the carbon oxygen coupling reaction developed in this
work. This methodology obviates one of the main drawbacks of diaryliodonium
chemistry; the need for a separate synthesis step and isolation before the desired
bond forming reaction can be carried out. This one pot synthesis method to form
diaryl ethers from aryl iodides is metal free, has less than a 3-hour reaction time,
at a low temperature of 55 oC, using mild potassium carbonate.

Figure 22. Telescoped synthesis of diaryl ethers from aryl iodides
The one pot telescoped synthesis of aryl(TMP)iodonium salts has been
previously reported, combining the oxidation of aryl iodide and ligand exchange
with

the

TMP

auxiliary

into

one

simple

reaction

but

telescoping

aryl(TMP)iodonium salt synthesis and a subsequent bond forming reaction have
not been previously reported.22,23
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The development of this work began when it was observed that
acetonitrile was a fairly good solvent for the carbon oxygen bond forming
reaction with an 85% yield at standard conditions (Figure 19). Acetonitrile is the
solvent that is used in the one pot synthesis of diaryliodonium salts reactions that
have been developed by our research group.22,23 The next step that was undertaken
was to run the diaryl ether synthesis reaction at standard conditions with each of
the biproducts from the first two steps added in sequence. Those bioproducts are:
meta-chlorobenzoic acid from meta-choloroperoxybenzoic acid, residual tosic
acid, residual acetonitrile, and residual TMB.
Acetonitrile is a functional solvent for the aryl coupling reaction and the
oxidation and ligand exchange steps are ran much more concentrated (1.0 M) than
the diaryl ether synthesis step (0.2 M) and as such the addition of acetonitrile had
little to no effect on the yield. The addition of meta-chlorobenzoic acid did result
in a slightly lower yield (~20% less). It was found that by increasing the
stoichiometry of base from 3 equivalents to 4 equivalents eliminated this drop in
yield. The addition of tosic acid and 1,3,5-trimethoxy benzene did not produce a
quantifiable effect on the reaction.
In a separate experiment it was found that meta-chlorobenzoic acid would
couple to aryl(TMP)iodonium salts but the reaction required temperatures in
excess of 85 °C; the synthesis of diaryliodonium salts via these methods is ran at
77 °C as it was found that running at higher temperatures resulted in
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decomposition of the diaryliodonium salt possibly via this benzoic acid coupling
reaction pathway.22

Figure 23. Scope of telescoped synthesis of diaryl ethers from aryl iodides
The scope of this reaction was investigated as shown in Figure 23. The
telescoped reaction tolerates polysubstituted aryl rings as well as phenols. The
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scope of potential aryl rings is limited in that electron rich diaryliodonium salts
are difficult to synthesize via the methods we use and generate a significant
amount of undesired biproducts that interfere with the diaryl ether synthesis
reaction. A wide range of electronic effects are tolerated on the phenol coupling
partner ranging from highly electron deficient (cyano 20, and aldehyde 26) to
electron neutral (3-iodo 4-chloro 23) to highly electron rich (methoxy 32). The
telescoped reaction shows moderate to good yields for all entries with an average
yield of 76%.
When comparing the results of the telescoped synthesis to the two-stage
reaction in the first three entries in table 16 it was found that the telescoped
method was slightly lower but comparable with the two-stage reaction with an
average overall yield of 74% for the telescoped and 83% for the two-stage
reaction. While the yields are slightly lower the telescoped reaction does have the
advantage of requiring only one purification step, less overall solvent and less
time investment than the two-step method.

Figure 24. Subsequent telescoped diaryl ether synthesis reaction
Figure 24 showcases the subsequent telescoped synthetic utility of this
method. Unlike metal catalysis phenols bearing (pseudo)halide synthetic handles
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can be used to generate products that are easily functionalized in subsequent
reactions. This two-pot reaction generated a highly functionalized polyaryl ether
in 75% overall yield by reacting diary ether product 23 in a subsequent telescoped
diary ether synthesis reaction to form polyaryl ether 32.
2.6 Synthesis of Novel Substrates
This reaction also demonstrates the synthesis of novel highly sterically
hindered diaryl ethers as well as unique chemoselectivity of heterocycles. Both of
these examples demonstrate a desired chemical moiety that was not able to be
synthesized in the literature.49,50 The chemistry developed here was able to
synthesize both of the desired compounds: the highly sterically encumbered
2,2’,6,6’-tetramethyldiphenyl ether as well as selectively reacting at 5 position
over the 2 position on a halogenated pyridine which under literature conditions
demonstrate a high preference for substitution at the 2 position. 51–54
2.6.1 Highly Sterically Hindered Diaryl Ethers
The highly sterically hindered 2,2’,6,6’-tetramethyldiphenyl ether (33) has
only been reported once in the literature but was not isolated; it was synthesized
via copper catalysis in 2% GC yield.50 The synthesis of this novel class of
chemicals could open up the possibility of new target molecules for use in the
pharmaceutical or agrochemical fields. Under the methods we developed this
compound was able to be isolated in 52% yield as demonstrated in Figure 25.
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Figure 25. Synthesis of highly sterically hindered 2,2’,6,6’-tetramethyldiphenyl
ether
2.6.2 Chemoselectivity of Heterocycles
Substituted pyridines are a common heterocycle present in many desirable
compounds, including antibacterial compounds. 49 Certain substitution patterns of
pyridine are highly difficult to synthesize due to the increased reactivity at the 2
and 4 positions on the pyridine ring.54 If a (pseudo)halide at the 2 or 4 position is
a desired chemical moiety that will interfere with the synthesis and result in
undesired side products (34) as demonstrated in Figure 26 when using copper
catalysis. 49
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Figure 26. Telescoped synthesis of substituted pyridine from aryl iodides via
diaryliodonium salts
Under our chemistry this selectivity can be overcome by the synthesis of a
diaryliodonium salt in-situ resulting in the desired product (35) and no side
products (34). We were able to synthesize the desired substituted pyridine (35) in
65% yield in under 3 hours at 55 °C, compared to the stoichiometric copper
reaction that requires 110 °C and 3 days to complete while only resulting in 7% of
the desired product (35) and forms more (11%) of the undesired 2 substitution
product (34) than the desired product.
This synthetic methodology allows for a wider range of substituted
pyridine compounds to be synthesized under mild conditions directly from readily
available pyridyl iodides in good yields with a short reaction time. These
compounds that were previously synthetically challenging have been desired as
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antibacterial agents and could quite possibly be capable of filling many other roles
as biologically active compounds.
2.7 Conclusion
In conclusion I developed a metal free synthesis of diaryl ethers from
diaryliodonium salts using mild base and mild conditions. This synthesis tolerates
a wide range of different aryl groups (Figure 20) as well as phenols (Figure 21)
including different electronic effects (electron rich to electron deficient), steric
effects (ortho, meta and papa substitution), and functional groups. I also
telescoped this reaction from aryl iodides to form the desired diaryl ether product
in one pot (Figure 23).
This reaction was also able to synthesize a highly sterically hindered
2,2’,6,6’-tetramethyldiphenyl ether (Figure 25) which was desired in the literature
but unable to be previously synthesized.

50

I was also able to achieve novel

chemoselectivity of substituted pyridines to synthesize a desired antibacterial
compound that was not able to be synthesized in the literature. 49
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3. Synthesis of Anti-Malarial ELQ 300
This work previously published as:
Pou, S.; Dodean, R. A.; Frueh, L.; Liebman, K. M.; Gallagher, R. T.; Jin, H.;
Jacobs, R. T.; Nilsen, R.; Stuart, D. R.; Doggett, S. J.; Riscoe, M. K.; Winter, R.
W. New Scalable Synthetic Routes to ELQ-300, ELQ-316, and Other
Antiparasitic Quinolones. Org. Process. Res. Dev. 2021, 25, 1841-1852.55
Author contribution: Riscoe and co-workers at OHSU and Dr. David R. Stuart
conceived of this project based on previous work done by Riscoe and co-workers.
All non diaryliodonium salt related research was carried out by members of
Riscoe and co-workers and their other collaborators. The development of the
diaryliodoniums salt mediated route to ELQ 300 was developed by Dr. Stuart, Dr.
Riscoe, Dr. Nilsen and me. I performed all diaryliodonium synthesis optimization
studies and synthesis reactions. I have written this chapter for my dissertation. I
characterized

all

diaryliodonium

related

molecules

and

compiled

the

diaryliodonium related sections of the supporting information. All other
compounds were characterized, and the rest of the supporting information for the
previously published work was compiled by Riscoe and co-workers and their
other collaborators.
Malaria is one of the widespread diseases currently affecting the world
with over 229 million reported cases and an estimated 409,000 deaths in 2019
alone.56 A major problem with the treatment of malaria is that the majority of
currently approved antimalarial drugs require repeat dosing that can be difficult to
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achieve in areas with limited medical resources where the disease is endemic.57,58
These gaps in treatment can result in worsening of the disease and the parasite
developing drug resistance. 59,60
This problem is further complicated by the developing resistance of
malaria to currently approved antimalarial drugs. Drug resistance in malaria was
first reported in in the mid-20th century in the form of chloroquine resistance.61,62
Since this discovery malaria parasites have evolved resistance to every
antimalaria approved for clinical use.60 In order to address these issues new
antimalaria drugs are desperately needed, specifically ones that are curative with a
single dose, easy to administer, active against all life stages of drug resistant
malaria and inexpensive to manufacture. Endochin-like Quinolones (ELQs) are a
category of drug candidate that has the possibility to answer all of these issues.
Endochin was first synthesized in 1940 by Andersag and colleagues and
was investigated as a possible antimalarial drug. The results of the malarial
screening were not ideal and the compound was not investigated further. 63 In
2000 a new class of Endochin derivatives were discovered that included the
addition of a quinolone group which is a known antibiotic as shown in Figure 27.
With the addition of this new group the resulting Endochin-like quinolones
(ELQ’s) were tested against malaria and found to be highly effective.64 ELQ
compounds display high antimalarial activity both in-vivo and in-vitro as well as
high parasite selectivity and low mammalian cell toxicity.
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Figure 27. Endochin and endochin-like quinolone 300
A problem facing this category of drug-like molecules is the lack of an
industrial scale synthetic route that is inexpensive and efficient. Endochin (38) has
been historically synthesized via the Conrad-Limpach reaction from an aniline
(36) and a β-keto ester (37) as shown in Figure 28. This reaction is very efficient
for Endochin itself producing the product in 2 steps. In the first step the ester and
amine are condensed to form β-anilinocronate; the second step is a heat driven
cyclization reaction to form the second ring system found in the Endochin product
(41).65–67

Figure 28. Synthesis of endochin via Conrad-Limpach reaction
This method however poses some problems when attempting to synthesize
the more highly functionalized ELQ compounds. This issue required a
reevaluation of the synthetic pathway and several different methods have been
investigated in an attempt to solve this problem.
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3.1 Previous Synthetic Routes
The synthesis of quinolones has been investigated by several research
groups under a variety of methods. One of the major fields of investigation has
been how to form the nitrogen containing aryl ring and at what stage of the
synthesis it should be formed. Under the Conrad-Limpach method that reaction is
the final reaction at the end of two converging synthesis to form the aniline and
the β-keto ester. There have been several synthetic alternatives developed to avoid
the high temperatures (250 °C) required by the Conrad-Limpach reaction.
If the amine containing ring of the quinolone can be synthesized under
different methods with a reactive chemical handle it could then be further
functionalized to form the desired Endochin-like quinolone products. This method
was demonstrated by Georg et all in 2009.68 Their synthesis involved forming
ynones (40) from substituted anthranilic acids (39) and a cyclization reaction to
form the desired quinolone product (41) as demonstrated in Figure 29.

Figure 29. Synthesis of quinolones via ynones
In 2010 the Manetsch research group demonstrated a palladium catalyzed
Suzuki-Miyaura methodology to substitute quinolones. 69 This reaction revolved
around forming the quinolone first then substituting it with an aryl halide
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followed up by a palladium catalyzed carbon-carbon coupling reaction as shown
in Figure 30. This methodology enables the synthesis of complex substituted
quinolones like ELQ’s. This reaction does have its issues, a mixture of products is
produced that can be very difficult to separate via column chromatography.

Figure 30. Suzuki-Miyaura synthesis of quinolones
By combining the theories from these works Riscoe and co-workers
developed a synthetic route to form ELQ 300. This route involved a parallel
synthesis of the quinolone fragment via Conrad-Limpach coupling (48) and the
diaryl either fragment (44) via classic Ulmann coupling and linking the two
fragments together via Suzuki-Miyaura coupling to form the desired ELQ product
(50) as shown in Figure 31. 55
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Figure 31. Previous total synthesis of ELQ 300
The protected quinolone type compound (48) performed much better than
the unprotected quinolone (47) in Suzuki-Miyaura coupling with the diaryl ether
fragment (44) and the product (49) was isolatable by column chromatography and
was easily deprotected to yield the desired ELQ 300 product (50). This total
synthesis avoids the previous issues of both the Conrad-Limpach reaction by
substituting the quinolone product afterwards as well as the isolation issues
present in the Suzuki-Miyaura coupling.
This reaction has been used to synthesize hundreds of grams of ELQ
compounds for testing, but it is not suitable for large scale industrial synthesis.
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The synthesis requires seven reactions, requires the use of an expensive palladium
catalysis in 2 separate reactions as well as stoichiometric copper, requires the use
of high vacuum distillation (reaction b) and several chromatographic isolations
(reactions b and f) as well as numerous recrystallizations.
In this work our research group and Riscoe and co-workers collaborated to
attempt to improve upon the synthesis of ELQ 300 by shortening the reaction and
removing expensive metal catalyzed steps by replacing them with iodonium salt
cross coupling reactions.
3.2 Synthesis via Diaryliodonium Salts
Diaryliodonium salts were explored as a possible alternative to the Ullman
coupling to synthesize the diaryl ether fragment (43), this would avoid the need
for stoichiometric copper as well as the need to purify the product via high
vacuum distillation to avoid copper contamination. Similar methodologies have
been previously published using symmetric diaryliodonium salts but the
production of stoichiometric aryl iodide waste made then unviable for large scale
synthetic synthesis.70,71 Unsymmetric(TMP)aryl iodonium salts are easy to
synthesize, use an economic and widely available TMB derived auxiliary ligand,
are totally chemoselective for the desired aryl coupling partner and are thermally
stable in the desired temperature operating window.22,32,72,73 The synthesis of the
diaryliodonium salt required for the diary ether synthesis (52) from the
corresponding aryl iodide (51) was investigated on large (>200g) scale as shown
in Figure 32.
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Figure 32. Large scale synthesis of diaryliodonium salt precursor for ELQ 300
This diaryliodonium salt was then investigated with a wide range of
coupling partners to produce a (pseudo)halogenated diaryl ether that could
participate in Suzuki-Miyaura coupling. The first product synthesized was the
para-bromophenyl diaryl ether (43) which was made in 89% yield for a total yield
of 76%. The para-iodidophenyl diaryl ether (55) was also synthesized in 95%
yield for a total yield of 83%. We then investigated the possibility of replacing the
Suzuki-Miyaura coupling with a copper catalyzed carbon-carbon bond formation
reaction using a diaryl iodonium salt (56) formed from the para-iodidophenyl
(55) as shown in Figure 33. Unfortunately, the carbon-carbon coupling reaction
did not produce the desired product. At this point the possibilities of
diaryliodonium chemistry had been fairly exhausted for the original synthetic
route that was envisioned by Riscoe and co-workers.

Figure 33. Synthesis of diaryl ether diaryliodonium salt
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After this point there was a significant lapse in our participation in this
project during which time Riscoe and co-workers redesigned the synthesis with
the idea to form a more heavily substituted β-Keto ester that contained the diaryl
ether fragment (57) and to perform the Conrad-Limpach reaction at the end of the
synthesis to avoid the Suzuki-Miyaura coupling required by the original synthesis
as shown in Figure 34.

Figure 34. New synthesis of ELQ 300
With this new synthesis in mind Riscoe and co-workers contacted us again
and asked us if the newly designed diaryl ether fragment could be synthesized via
diaryliodonium chemistry. The first reaction that we investigated was the
coupling of the (para-trifluoromethoxypehny)(TMP)iodonium salt (53) with 1-(4hydroxyphenyl)-2-propanone (60) as shown in Figure 35. This was chosen as the
initial candidate due to the very low cost of 1-(4-hydroxyphenyl)-2-propanone
(60) and the ease of converting the product (61) into the desired β-Keto ester
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(57).74 The reaction showed initial promise with a 55% NMR yield but the
product was not able to be isolated via silica or alumina column chromatography
due to coelution with the 2,4,6-trimethoxyphenyl iodide (TMPI) biproduct (62).

Figure 35. Synthesis of diaryl ether fragment using 1-(4-hydroxyphenyl)-2propanone (60)
The inability to isolate this product via column chromatography led to an
investigation of other possible isolation methods. The product (61) has a boiling
point of 343 °C which makes distillation an impractical method of isolation. 74 The
next purification method we investigated was recrystallization. The reaction
mixture could be mostly purified via a mild aqueous base wash of potassium
carbonate which removes all residual alcohol (60) and carbonate resulting in a
toluene solution of the product and TMPI. When this solution was concentrated
and placed into a freezer at -20 °C for 24 hours crystals were observed. When
these crystals were filtered, and dried NMR data determined that they were TMPI
(62) crystals. Using this method, it is possible to achieve purities of 80-85% as
determined by QNMR without losing significant (>5%) product.
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The next possible synthetic pathway that we investigated was to react to
the diaryl ether diaryliodonium salt (55) with ethyl acetoacetate (63) to form a
more highly functionalized intermediate (64) as shown in Figure 36. No product
was observed under my standard conditions so numerous other reaction
conditions were investigated. These include different bases such as cesium
carbonate, sodium hydride and sodium tert-butoxide as well as different reaction
times temperatures solvent and equivalents but unfortunately the desired product
(72) was never observed.

Figure 36. Synthesis of diaryl ether fragment using ethyl acetoacetate
We then investigated the possibility of using the phenol (65) that would
directly form the diaryl ether fragment (56) used in the synthesis in Figure 34.
This reaction shared the same isolation issues as the synthesis using 1-(4hydroxyphenyl)-2-propanone (60) but was able to be mostly purified by the same
base wash and recrystallization method as that product. The yield of the product
(56) was disappointingly low (43%) as shown in Figure 37.
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Figure 37. Published ELQ 300 diaryl ether fragment synthesis
The reaction conditions for this reaction were investigated and optimized
and it was found that by switching from potassium to cesium carbonate and by
raising the equivalents of phenol from 1.5 to 3 the yield could be raised from 43%
to 54%. This results in an overall yield of 45% to synthesize the desired diaryl
ether fragment (56) via diaryliodonium chemistry. Unfortunately, the low yield of
this reaction pathway and the requirement for a recrystallization and a column
purification in addition to the isolation of the diaryliodonium salt itself meant that
it was not a viable industrial synthetic pathway.
The final synthetic pathway that was chosen to make the diaryl ether
fragment was an Ullmann coupling reaction with a phenolic carboxylic acid
followed by an acid catalyzed esterification reaction with ethanol to form the
desired diary ether as shown in Figure 38. This reaction has a higher overall yield
(71% compared to 45%) and does not require chromatographic separation
compared to the diaryl iodonium salt synthesis pathway.
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Figure 38. Synthesis of Diaryl Ether Fragment Via Ullmann Coupling
3.3 Synthesis of antimalarial ELQ 300 conclusion
In this project I synthesized a diaryl ether that was desired as a synthetic
fragment of antimalarial ELQ-300 from a diaryliodonium salt, in order to improve
upon the previously published synthesis of this molecule. 55 I synthesized the
diaryl iodonium salt on large scale (>200g), and synthesized a wide variety of
diaryl ether molecules that were potential fragments of the desired antimalarial
ELQ-300.
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4. Alky-Aryl Ether Synthesis
Author contribution:
This project is a continuation of work devised by Dr. David R. Stuart and
Dr. Sunil K. Sundalam.33 The idea for this project was conceived by Dr. Stuart
and myself. I performed the optimization of all conditions including mild base
screen, final optimization and optimization of telescoped reactivity. Shubhendu
Karandikar performed the mechanistic studies of alkyl-aryl ether coupling. I
wrote this chapter for my dissertation. I isolated and characterized all compounds
in the scope and performed the literature comparison study for all compounds. I
have compiled a preliminary draft of the supporting information for this work
containing all current scope entries. Any further work required for the publication
of this project will be carried out by Shubhendu Karandikar.
Alkyl-aryl ether moieties are found in many different industries including
high-tech, pharmaceuticals and agrochemicals as shown in Figure 39. Many of
these synthetic targets are quite large and structurally elaborate and several
different synthetic pathways have been investigated to produce them. The most
attractive of these feature a convergent synthesis that couples a complex aryl
group with an alkyl fragment to form a new carbon oxygen bond.
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Figure 39. Representative products of alkyl-aryl ether synthesis
4.1 Literature Arylation of Alcohol Nucleophiles
The most common classic methods in the literature to accomplish this
transformation are the Williamson ether synthesis, the related condensation
reactions and the Mitsunobu reaction.75–77 These reaction pathways are often
limited by the requirement of toxic alkylating agents, harsh reaction conditions of
high temperatures and strong acids as well as limited substrate scope.
An often used alternative to these strategies is nucleophilic aromatic
substitution (SNAr) via alkyl metal alkoxides and aryl halides.78 SNAr does have
some shortcomings, specifically it is limited to specific substitution patterns and
requires electron deficient aryl groups.79 Another area of study to form alkyl-aryl
ethers that has received a lot of focus in recent years is transition metal catalysis
and ligand development.80–83 While transition metal catalyzed reactions tend to be
very efficient and high yielding; transition metal free reactions have an
environmental and economic advantage over transition metals due to the lack of
expensive metals and ligand and requirement of metal remediation processes.
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Diaryliodonium salts have been investigated as a possible transition metal
free alternative to synthesize alkyl-aryl ethers and are well known to produce
these products under mild conditions.18,19,33,47 The majority of these studies utilize
symmetric diaryliodonium salts to guarantee the desired coupling partner is
produced. When unsymmetric diaryliodonium salts have been used in the past
they have shown a lack of electron rich aryl group reactivity and have also had
issues with oxidation and aryne formation side reactions. 33,84
In this work we will demonstrate the syntheses of alky-aryl ethers from
unsymmetric aryl(TMP)iodonium salts, compare this chemistry to recently
published work in diaryliodonium, nucleophilic aromatic substitution and
transition metal catalysis alkyl-aryl ether synthesis and examine the mechanism of
this reaction to elucidate the various reaction pathways (ipso substitution, aryne
formation and oxidation) and determine what reaction conditions result in each
pathway being favored over the other two. Another goal of this project is to
demonstrate electron rich aryl group reactivity of diaryliodonium salts.
4.2 Optimization of the reaction
The majority of previous diaryliodonium salt synthesis pathways to access
alkyl-aryl ethers made use of symmetric diaryliodonium salts and strong bases.
When

we

first

investigated

this

reaction

using

the

unsymmetric

tolyl(TMP)tosylate iodonium salt (66) and the strong base sodium hydride we
discovered the presence of the meta regioisomer (68) in the crude NMR spectrum
as shown in Figure 40.
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Figure 40. Tolyl(TMP)iodonium alkyl-aryl ether synthesis and production of
meta regioisomers
This undesired reaction pathway had been previously published by
Olofsson and co-workers using symmetric diaryliodonium salts and strong base.
They proposed that an aryne intermediate was responsible for this undesired
reactivity, aryne synthesis from diaryliodonium salts has been reported in the
literature which lends support to this theory.48,85–89 We theorized that by switching
to TMP as the auxiliary ligand and using a mild base this reaction pathway could
be mitigated allowing for a wider range of products to be synthesized in high
yields and isolated purely.
4.2.1 Synthetic Challenges
There were three main synthetic challenges that we sought to overcome in
the synthesis of alkyl-aryl ethers via diaryliodonium salts. The traditionally low
yields of electron rich aryl groups; formation of regioisomers via an aryne
reaction pathway; and the oxidation of alcohols to carbonyls. 33,84 We theorized
that by switching to mild base we would mitigate the aryne formation side
reaction as most aryne synthesis reaction are reported using strong bases. 48,85–89
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In the literature when using a strong base, a prestir step is often employed
to deprotonate the alcohol before the addition of the diaryliodonium salt. 18,19,33,84
By using mild base we make this prestir stage unnecessary as the mild bases we
investigated were not strong enough to fully deprotonate alcohols in-situ. The
mechanism for this oxidation reaction proposed by Olofsson and co-workers
requires the alkoxide to be present. We postulate that by using mild base the
alkoxide should only be formed in minimal amounts in solution or after
associating with the diaryliodonium salt which should lower this oxidation
pathway and result in more ipso substitution product formation.
In my previously published work on diaryl ether synthesis the TMP
auxiliary ligand has been shown to increase the reactivity of electron rich aryl
groups in diaryliodonium mediated ether synthesis.32 We hoped that by using
unsymmetric aryl(TMP)iodonium salts and mild base we could increase the
reactivity of electron rich aryl groups in alkyl-aryl ether synthesis.
4.2.1.1 Aryne Formation
Aryne formation via diaryliodonium salts has been reported as early as the
1970s.88 This reaction has been studied extensively and has been demonstrated to
perform many useful transformations and synthesize novel highly sterically
encumbered products.89,90 While it can be highly synthetically useful this reaction
pathway posed a problem for our chemistry as it produces regioisomers that are
very difficult to separate from the desired product via column chromatography.
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Olofsson and co-workers investigated these competing pathways in
2017.84 They reacted an electron rich symmetric ditolyliodonium triflate salt (69)
with n-pentanol which had been deprotonated to n-pentoxide in a prestir step by
sodium tert-butoxide as shown in Figure 41.

Figure 41. Aryne reaction pathway via strong base and symmetric
ditolyliodonium salt
This reaction had an 80:20 ratio of the desired para substitution product
(67) to the undesired meta substitution product (69). Olofsson and co-workers
postulate that this reactivity is due to the formation of an aryne intermediate. That
aryne intermediate could react at either of its two aryne carbons as shown in
Figure 42.
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Figure 42. Aryne formation and ipso substitution reaction pathways in alkyl-aryl
ether synthesis via diaryliodonium salts
This implies that 50% of the aryne that is produced goes on to form the
desired para substitution product and that the ratio of reaction pathways is 60:40
ipso substitution to aryne formation. When furan was added to the reaction the
Dies- Alder product of the aryne and furan was observed in 9% while the ipso
substitution product (69) was observed in 36% yield further reinforcing the aryne
formation hypothesis. Olofsson and co-workers also report the formation of these
regioisomeric products when using secondary and tertiary alcohols.
4.2.1.2 Oxidation of Alcohols
Hypervalent iodine reagents are often used as oxidizing agents, but
diaryliodonium salts are poor oxidants compared to other hypervalent iodine
reagents that feature heteroatomic ligands.91 McEwen and co-workers have
postulated a radical pathway to explain this oxidative transformation. 92 Olofsson
and co-workers however state that this pathway does not proceed via a radical
mechanism. They propose the mechanism shown in Figure 43. This oxidation
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reaction pathway would result in the decomposition of the diaryliodonium salt
which would negatively impact ipso substitution yields.

Figure 43. Oxidation of alcohols via diaryliodonium salts
This reaction is especially dominant when using benzylic and aliphatic
alcohols.18,19 Olofsson and co-workers decided to test this reaction using a
secondary benzylic alcohol that should be the ideal candidate for this oxidation
reaction to occur. They found that when reacting symmetric diphenyliodonium
triflate (70) with α-methyl benzyl alcohol (69) the ketone oxidation product (72)
was the major product formed. As shown in Figure 44 the reaction produced only
21% of the desired ipso substitution product (71) and 60% of the ketone (72).
When the TEMPO and DPE radical traps were added to these reactions the yield
of ketone was not affected which lends evidence against the radical mechanism
proposed by McEwen.
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Figure 44. Reaction of secondary benzylic alcohol with diaryliodonium salt
A similar reaction was reported in 2015 by Stuart and co-workers that did
not exhibit this oxidation product. When reacting the unsymmetric metafluorophenyl(Mes)bromide iodonium salt (74) and benzyl alcohol (73) only trace
amounts of oxidation product was observed with a 78% isolated yield of the ipso
substitution product (75) as shown in Figure 45.33

Figure 45. Synthesis of benzyl alcohol containing alkyl-aryl ether via
unsymmetric diaryliodonium salt
This result compares favorably to the results observed by Olofsson and coworkers when using symmetric diaryliodonium salts as shown in Figure 42. When
Olofsson

and

co-workers

reran

the

reaction

using

the

unsymmetric

phenyl(Mes)bromide iodonium salt and α-methyl benzyl alcohol they discovered
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that the ketone was still the major product and that the selectivity of the ipso
substitution pathway was only 2:1 in favor of the phenyl group over the mesityl
group. This illustrates that the Mes auxiliary group requires electron deficient aryl
groups to be a functional auxiliary.
4.2.2 Mild Base Screen and Final Optimization
With these synthetic challenges in mind we return to our initial conditions
as shown in Figure 40. By switching from the symmetric ditolyl triflate iodonium
salt to the unsymmetric tolyl(TMB)tosylate diaryl iodonium salt (66) the yield of
the undesired meta regioisomer (68) dropped from 10% (Figure 41) to 5% (Figure
40) but the yield of the desired product (67) was 40% in both reactions. We then
turned our attention to determining the effectiveness of mild bases for this
reaction. We screened many different base and diaryl iodonium salt counter anion
combinations as shown in Figure 46. We chose the para-tolyl group for this
screen because Olofsson and co-workers had reported the highest yields of the
undesired meta regioisomer when using they symmetric ditolyl triflate iodonium
salt (69).
While sodium hydride has high yields for the desired para substitution
product it had an average of 4% regioisomer for its highest yielding counter anion
combinations. Cesium carbonate demonstrated a high yield with both tosylate and
trifluoro acetate (TFA) and only a 2% average yield of the meta regioisomer. We
selected cesium carbonate and the tosylate counter anion because they had the
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highest average yield of the desired para substitution product (67) and the lowest
yield of the undesired meta substitution product (68).
O
n-Butanol (1.5 equiv)
Base (3 equiv)

X
I
TMB

Toluene 55 oC
2 hours
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O
68
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Counter
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Figure 46. Screen of Mild Bases and Counter Anions for Alkyl-aryl Ether
Synthesis
The results of this base screen afforded as a reaction that produced the
desired para substitution product (67) in 54% yield with only 2% of the undesired
meta regioisomer (68). The ratio of 25:1 observed in this reactivity is a major
improvement on the 4:1 ratio exhibited in Olofsson’s work, but the yield of the
desired product was still fairly low. We then embarked upon a final optimization
to attempt to increase the yield. We screened reaction time, temperature, solvent,
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concentration, equivalent of alcohol and base using out tolyl(TMB)tosylate salt
and cesium carbonate. We discovered that the optimal conditions were the
standard conditions we ran our optimizations at: 1.5 equivalents of alcohol, 3
equivalents of cesium carbonate, toluene as the solvent, with a reaction time of 2
hours and temperature of 55 °C.
4.2.3 Telescoping Alkyl-aryl Ether Synthesis from Aryl Iodides
As with the diaryl ether synthesis project we attempted to telescope this
reaction to form the product directly from the aryl iodide in one pot in order to
alleviate the concern of needing to synthesize and isolate the diaryliodonium salts
in a separate reaction stage. We once again chose para-tolyl(TMB)tosylate (66) as
our model substrate as electron rich aryl groups have shown poor reactivity in the
literature. Unfortunately, this methodology was significantly less effective when
using alcohols instead of phenols resulting in a 25% drop in yield compared to the
two-pot method as shown in Figure 47.
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Figure 47. Telescoped alkyl-aryl ether synthesis compared to two-pot alkyl-aryl
ether synthesis
We attempted to determine the source of this drop in reactivity by adding
each of the components of the oxidation and ligand coupling reactions to the ether
formation reaction as shown in Figure 38.

62

Figure 48. Alkyl-aryl ether synthesis with biproducts of telescoping oxidation and
ligand exchange reactions sequentially added
The standard conditions (entry 1) result in a yield of 55% and minor
deviations from that yield can be assumed to be experimental error and not a
statistically significant difference. The addition of the aryl iodide (entry 4) and the
three-hour reaction time (entry 8) both fall solidly within 5% of the standard
conditions and as such can be assumed to be within experimental error. The
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addition of TMB (entry 5) and tosic acid (entry 3) both resulted in a minor
increase in yield, but those yields were barely over 60% and as such can probably
be discounted as well.
The two main factors that are responsible for the decrease in yield are the
presence of 3-chlorobenzoic acid (entry 2) (the biproduct of mCPBA after the
oxidation reaction) and the presence of acetonitrile (entries 6-7). The presence of
3-chlorobenzoic acid does not lead to the production of ester carbon oxygen
coupling products unless the temperature is above 70 °C as determined in my
previous telescoping experiments.32 We hypothesize that the benzoic acid is able
to outcompete the alcohol to associate with the diaryliodonium salt which is
required in order for the weak base to deprotonate the alcohol and begin the
reductive elimination reaction that results in the desired ipso substitution product.
This results in molecules of our diaryliodonium salt being unable to form product.
When we examined the crude NMR we did find about 30% unreacted
diaryliodonium salt where usually none is present, which lends evidence to this
theory.
The other main factor leading to the decrease in yield is the presence of
acetonitrile. When acetonitrile is used as the only solvent (entry 6) the yield drops
from 55% down to 15% which is a huge drop. When one milliliter of acetonitrile
is added, (entry7) (which is the reaction volume of the first two steps in the
telescoped reaction) to the 5 milliliters of toluene that is used in the reaction the
yield drops from 55% to 32%. The yield of the telescoped reaction was 30%
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(Figure 47) and is within experimental error of the ether formation reaction with
acetonitrile added.
We determined the acetonitrile to be the main culprit behind our reduced
reaction yields and set out to find alternative solvents that we could use in the first
reaction step. The aryl(TMP)iodonium tosylate salt synthesis procedure that is the
basis of the first two stages of the telescoped reaction investigated
dichloromethane as a possible solvent for the salt synthesis reaction. 22 From our
own solvent screen we knew that dichloromethane was a much better solvent than
acetonitrile for the ether formation reaction. We then attempted a telescoped
reaction using dichloromethane as the solvent for the first two reaction stages as
shown in Figure 49.

Figure 49. Telescoped synthesis of alkyl-aryl ethers using dichloromethane as
solvent one
This change resulted in a yield of 40% which is exactly the same yield as
our addition experiment with meta-chlorobenzoic acid, (Figure 48 entry 2) which
was now our main issue to resolve. Initially we tried several other oxidants
(Oxone, Selectfluor, and hydrogen peroxide) instead of meta-chlorobenzoic acid
but none of them resulted in quantifiable yields of the desired alkyl-aryl ether
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product. We then examined the possibility of a solvent switch to remove the metachlorobenzoic acid from solution.
Diaryliodonium salts can be purified by a process called trituration, where
a cure reaction mixture is dissolved in a large volume of diethyl ether. The
byproducts of the diaryliodonium salt synthesis reaction are all soluble in diethyl
ether but the diaryliodonium salt is not and will precipitate out of solution and can
be purified in high yield via filtration.22,73 We envisioned performing this
purification technique on a small scale directly in the reaction vessel by adding
diethyl ether after the first two stages of the reaction a shown in Figure 50. We
would then decant the diethyl ether solution removing any contaminants and
leaving solid diaryliodonium salt in the reaction vessel. We could then add our
second solvent (toluene) and proceed with the next step of the reaction.
Unfortunately, this procedure only resulted in a 43% yield which is only
marginally higher than the yield when using dichloromethane as solvent one
(40%). Since the solvent switch resulted in similar yields as switching to
dichloromethane for solvent one we decided to not pursue it further as it requires
an additional process when performing the one pot reaction.
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Figure 50. Telescoped alkyl-aryl ether synthesis featuring trituration and solvent
switch
We then decided to test our telescoping method on a more reactive
electron deficient diaryliodonium salt to determine if these moieties performed
better than electron rich diaryliodonium salts. We chose para-methylester
iodobenzene (76) as it performs very well in diaryliodonium ether formation
reactions.32 This reaction also showed a marked drop in yield of 56% down from
91% when using acetonitrile as solvent one when compared to the two-stage
reaction. (Figure 51) When we performed the reaction with dichloromethane as
the first solvent we saw a 17% increase in yield to 73% as shown in Figure 51.
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Figure 51. Telescoped alkyl-aryl ether synthesis using electron deficient para
methyl ester
The results of our alkyl-aryl ether telescoping studies were not as
promising as our previous diaryl ether telescoping study and required undesirable
halogenated solvent (DCM) or a separate reaction stage (trituration and solvent
switch) and as such we decided to not pursue them further.

4.3 Scope and Comparative Studies to Previous Literature Reports
When determining which substrates to test for the scope of this reaction
we decided to perform a wide-ranging literature search of various methodologies
to synthesize alkyl-aryl ethers and test substrates that had literature comparators.
We focused our search around the common synthetic pathways to access alkylaryl ethers: common transition metal catalysis (palladium, and copper),
nucleophilic aromatic substitution, and other catalytic reactions (Cobalt, nickel,
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ruthenium). We also surveyed other diaryl iodonium synthesis methodologies to
access these compounds. The full scope of the reaction is demonstrated in Figure
12.18,19,33,93–115 A full description of all references can be found in Supplemental
Information Appendix 1.
The results in red labeled RG are those of our work, the results labeled by
an element (Pd, Cu, Ni, Co, Re) are literature catalytic reactions those labeled by
I3 are literature diaryliodonium reactions, and the results labeled S NAr are
nucleophilic aromatic substitution reactions. All literature results listed are the
most recent of all possible reports of that compound synthesized under that
methodology. Many of the metal catalysis reactions examined several different
aromatic halides as possible coupling partners, if aryl iodide was examined the
yield of that reaction is the one reported if it is not then the highest yield of all
possible aryl groups is reported. Compound 94 (structure highlighted in red) was
the only product that produced quantifiable amounts of the meta regioisomer, the
product and regioisomer were isolated together in a 19:1 ratio of the desired para
product to the undesired meta regioisomer.
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Figure 52. Scope of alkyl-aryl ether synthesis and literature comparison
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While conducting our literature search and identifying possible candidates
for this scope table we decided to focus our attention on several key groups that
had presented issues for diaryl iodonium salt alkyl-aryl ethers in the past. The first
was electron rich aryl groups which are not widely reported and when they are
reported often in poor yields in diaryliodonium chemistry. Electron rich scope
entries 81-83, 90 and 93 demonstrate middling to good yields that are fairly
competitive with the literature comparators (65% average yield compared to the
literature average of 69%). We also demonstrated electron rich reactivity in ortho
meta and para positions as shown by scope entries 81-83.
Another issue that had been negatively affecting diaryliodonium mediated
alkyl-aryl ether synthesis is the formation of arynes which leads to undesired
regioisomers that are difficult to separate from the reaction mixture. This side
reaction is especially prevalent when using electron rich aryl groups and
secondary alcohols.84 When using the chemistry developed here the only reaction
that produces quantifiable amounts of regioisomers was the formation of scope
entry 16 and in that case in a marginal 19:1 ratio in favor of the desired para
substituted product. We tested a wide range of electron rich aryl rings (81-83, and
90) as well as secondary alcohols (84-86, 94) and other than entry 93 none of
them produced quantifiable amounts of the meta regioisomer. This reaction is
significantly more efficient than literature comparators when using secondary
alcohols with an average yield of 86% compared to the literature average of 67%
yield.
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The oxidation of benzyl alcohols to carbonyls has also been cited as an
issue in previous diaryliodonium alkyl-aryl ether synthesis. 84 For this work we
tested benzyl alcohol with a range of different aryl groups from electron poor to
electron rich (87-92) as well as different substitution patterns (91-92) and found
that the ipso substitution product formed in reasonable yields that were
competitive with the literature. (69% average yield compared to the literature
average yield of 66%) The carbonyl oxidation product was not isolated from any
of these benzyl alcohol reactions.
2,2,2-Trifluoro ethyl ethers are a prominent motif in many important
industries

including

materials

science

agrochemistry

and

especially

pharmaceuticals.93 This is largely due to the increased metabolic stability and
lipophilicity of fluorinated compounds when compared to other alkyl-aryl
ethers.94 Due to this widespread interest and quantity of publication we decided to
investigate this series of compounds using our chemistry. Our chemistry was able
to synthesize aryl trifluoro ethyl ethers with a variety of electronic and steric
effects ranging from highly electron deficient (78) to electron neutral (79-80) to
electron rich (81-83). We were also able to synthesize ortho meta and para
substituted trifluoro ethyl ethers (81-83). Our chemistry demonstrates competitive
yields (average of 72%) to literature procedures (79%) when synthesizing these
molecules.
The scope of this reaction demonstrates competitive results (76% average
yield) to current literature procedures (74% average yield) while using metal free
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conditions, low temperature, short reaction time, mild base and easily synthesized
unsymmetric diaryliodonium salts. It is effective across a wide range of electronic
and steric effects and demonstrates high selectivity for the desired ipso
substitution pathway over competing aryne formation and oxidation reaction
pathways.
4.4 Conclusion
I have also developed a methodology to synthesize alkyl-aryl ethers using
unsymmetric aryl(TMP)tosylate diaryliodonium salts. This methodology was
compared to a wide range of literature methods including metal catalysis and
nucleophilic aromatic substitution (Figure 52) and was found to be competitive
(76% average yield) to the literature procedures (74% average yield) while using
metal free conditions, mild base, low temperatures and short reaction times. This
methodology also overcame a reported issue of competing reaction pathways
when coupling alcohols with electron rich diaryliodonium salts that resulted in the
formation of arynes and meta regioisomers that are difficult to separate from the
product. It had also been reported that benzyl alcohols would undergo an
undesired oxidation pathway when reacted with diaryliodonium salts that resulted
in low yields and the formation of undesired aldehyde and ketone biproducts. The
conditions I developed tolerate benzyl alcohols and produce the desired products
in competitive yield (68% yield) when compared to other literature procedures
(66% yield)
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5. Other Projects and Collaborations
While the main focus of my work has been ether formation via
unsymmetric aryl(TMP)tosylate diaryliodonium salts and synthetic applications
of that chemistry I have also contributed to several other projects and
collaborations. The most productive of these projects have been solid phase anion
metathesis of diaryliodonium salts and the Stuart group collaboration with the
Otava Chemicals chemical supply company.73,95
Counter anion metathesis is a necessary procedure in diaryliodonium
arylation chemistry as many of the synthetically useful counter anions cannot be
directly synthesized and a separate counter anion metathesis reaction stage is
required to produce the desired counter anion. (Figure 53) Counter anion efficacy
must be determined empirically when optimizing diaryliodonium salt mediated
arylation reactions and a wide range of possible counter anions are required for
testing and thus counter anion metathesis reactions are also required. 22,23,73,96

Figure 53. Counter anion metathesis of diaryliodonium salts
A commonly cited issue with diaryliodonium salt chemistry is the
necessity of a separate reaction stage and isolation to produce the diaryliodonium
salts necessary for this chemistry. In my previous work we investigated
telescoping this reactivity directly from aryl iodides to circumnavigate this issue
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we also investigated commercial availability as an option to enable
diaryliodonium salt chemistry.32,95 In our collaboration with the Otava Chemicals
chemical supply company I maintained an inventory of diaryliodonium salts (>75
entries) that are available for commercial sale. I also perform quantitative NMR
quality checks and package and ship orders to clients. We hope that by making
these reagents available commercially it would increase their use and notoriety in
the chemical synthesis field.
5.1 Diaryliodonium Counter Ion Metathesis
This project has been previously published as:
Gallagher, R. T.* Seidl, T. L*; Bader, J.; Orella, C.; Vickery, T.; Stuart, D. R.
Anion Metathesis of Diaryliodonium Tosylate salts with a Solid-Phase Column
Constructed from Readily Available Laboratory Consumables. Org. Process. Res.
Dev. 2019, 23, 1269-1274.73
*co-first author
Author contribution:
This project was conceived by Dr. Thomas L. Seidl and Dr. David R. Stuart. All
optimization was performed by me and Dr. Seidl. All scope entries and reusability
study reactions were carried out by me. All DSC safety and stability studied were
carried out by Joshua Bader, Chuck Orella and Thomas Vickery via Merck and
co. I have written this chapter for my dissertation. I isolated and characterized all
compounds and compiled the supporting information for the paper.
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Counter anion metathesis is a necessary process when investigating
diaryliodonium salt synthesis reactions. Some counter anions are easily
synthetically available during the synthesis of the diaryliodonium salt (OTs, BF4,
OTf) however there are ten or more counter anions commonly investigated for
diaryliodonium arylation reactions during optimization.96 The counter anion has
effects on the stability, reactivity, and solubility of diaryliodonium salts and these
effects must be empirically determined and thus many different diaryliodonium
salts with different counter anions must be synthesized.
Previous literature methods of diaryliodonium salt counter anion
metathesis rely upon a biphasic salt metathesis approach which requires a large
excess of exchange salt and in some cases require multiple reaction stages to
achieve complete conversion to the desired counter anion.22,96 This process also
necessitates a liquid-liquid extraction to separate the diaryliodonium salt from the
aqueous excess exchange salt which uses large volumes of organic solvents. In
this work we sought to develop a process that mitigated the issues of excess
exchange salt and large volumes of organic solvent.
5.1.2 Literature Diaryliodonium Salt Counter Anion Metathesis
Previous literature methods of diaryliodonium salt metathesis reactions
rely upon a large excess of exchange salt dissolved in water. This concentrated
salt solution is then either mixed vigorously with an organic diaryliodonium salt
solution for a significant amount of time (~15-24 hours) or heated until boiling
and the diaryliodonium salt is dissolved in the boiling aqueous salt solution. The
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high concentration of exchange salt drives the reaction equilibrium towards the
desired counter anion. 22,96
This process requires a vast excess of exchange salt (20 to 100
equivalents) which poses an issue for large scale production as well as economic
constraints when using an expensive exchange salt. It also requires a long reaction
time and a liquid-liquid extraction step that requires large amounts of organic
solvent to avoid emulsions which are common when using liquid-liquid
extractions to purify diaryliodonium salt. These issues collectively make this
process undesirable on larger industrial scales and difficult to perform on a small
scale in a research laboratory.
5.1.3 Solid Phase Column Counter Anion Exchange
This project was first envisioned by Dr. Thomas Seidl during a synthesis
of an aryl(TMP)iodonium tosylate salt that was intended to be converted into a
aryl(TMP)iodonium bromide salt. While the salt was drying on a fritted glass
filter funnel an aqueous solution of sodium bromide was poured over the powder
and then drained from the frit. When analyzed the resulting aryl(TMP)iodolium
salt had been converted to the bromide in high yield and purity. Dr. Seidl and Dr.
Stuart then envisioned a possible counter anion metathesis that was the reverse of
the observed process, a solid phase column made out of the exchange salt that an
organic solution of diaryliodonium salt could be passed through to enable
exchange. This process would avoid the liquid-liquid extraction step as well as
allow for a more efficient use of exchange salt.
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My work on this project began at this stage of the project where we sought
to turn this idea into a practical process that would be possible with supplies that
are found in most research laboratories. The initial process we investigated was
the use glass chromatography columns that are ubiquitous in chemical synthesis
laboratories. While this process was functional it required a glass column for each
possible exchange salt which requires a large amount of laboratory resources. We
then decided to investigate the possibility of using disposable plastic syringes as
the cartridge to contain the exchange salt column. Based on initial testing it was
found that 60 milliliter plastic syringes were an ideal size to contain the amount of
exchange salt required for full conversion as shown in Figure 54.

Figure 54. Solid phase exchange salt column used for diaryliodonium salt counter
anion metathesis
In order to assemble these columns, the bottom of a 60-milliliter plastic
syringe is covered in cotton (a) then a layer of sand (b) followed by the solid
exchange salt (c) then a final layer of sand on top (d). The diaryliodonium salt is
then dissolved in organic solvent and allowed to gravity drain through the column
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which is then washed with more organic solvent to ensure that all diaryliodonium
is removed from the column. This process allows for quick (<10 minutes)
conversion of the aryl(TMP)tosylate salt to the desired counter anion in high yield
and purity.
We chose aryl(TMP)tosylate diaryliodonium salts as our substrate due to
the ease of synthesis of these reagents and wide range of possible aryl groups that
can be synthesized in one pot from aryl iodides.22 We then ran an optimization
screen for many conditions using out model system of aryl(TMB)tosylate
diaryliodonium salts, 60 milliliter plastic columns and solid exchange salt. We
first examined possible organic solvents that would enable the conversion of
diaryliodonium tosylate salts to the desired counter anion without adding
exchange salt impurities to the final product.
A wide range of organic solvents was tested including toluene,
dichloromethane, acetonitrile, and methanol. It was found that dichloromethane
had both high yields and high conversion rates to the desired counter anion. We
then tested the solubility of our desired exchange salts in dichloromethane to
determine if exchange salt contamination of the desired product was likely. All of
the exchange salts we examined (NaOTf, NaTFA, NaBr, and NaBF4) were found
to have negligible solubility in dichloromethane (0.01-0.02 M).
We then examined the equivalents of exchange salt, volume of
dichloromethane used to dissolve the diaryliodonium salt, volume of
dichloromethane used to wash the column and the use of pressure to speed up the
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flow of the column. We chose 2 millimoles as our amount of diaryliodonium salt
as that is more required to perform a full optimization study for a particular
counter anion (0.1 millimole per NMR scale reaction). It was found that the
equivalents of exchange salt required varied between the various exchange salts,
this is also true of other methods in the literature. We found decreasing the
volume of dichloromethane used to dissolve the diaryliodonium salt below 20
milliliters lead to a decrease in yield, and that decreasing the wash volume below
80 milliliters of dichloromethane also resulted in a decrease in yield. When we
examined the use of pressure it led to the column clogging during the reaction and
the column ran smoother and faster when only using gravity filtration. This
optimization led us to the standard conditions shown in Figure 55. After the
standard reaction the dichloromethane solution is concentrated and triturated
using methyl tert-butyl ether and the resulting solid is filtered to purify the
diaryliodonium salt.

Figure 55. Standard condition for exchange salt solid column counter anion
metathesis of diaryliodonium salts
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5.1.3.1 Scope and Reusability of Solid Phase Counter Anion Metathesis of
Diaryliodonium Salts.
We examined a wide range of aryl groups and exchange salts under our
standard conditions including as shown in Figure 56. The first number listed
under each product is the isolated yield and the number in parathesis next to it in
parenthesis is the conversion from tosylate to the desired counter anion. There are
some deviations from out standard conditions notably entries 98-101 required a
sand admix to avoid clogging issues and entries 101 and 105 required a 95%
dichloromethane 5% methanol solution to dissolve the diaryliodonium salt.

Figure 56. Scope of diaryliodonium counter anion metathesis via solid phase
column
The reaction shows good yields (average of 84%) and nearly quantitative
conversion across several substrates. Diaryliodonium salts bearing electron rich
81

(99 and 103), electron deficient (90 and 102), and electron neutral (100 and 104)
aryl groups were investigated as well as heterocyclic diaryliodonium salts (101
and 105). The reaction does show lower conversion rates when the scale is
increased to large scales as shown in entry 102 where a 20 millimole scale
reaction resulted in a product that was only 95% converted to the desired counter
anion and still contained 5% of the tosylate starting material.
The solid columns of packed exchange salt require similar or higher
equivalents of the exchange salt than the traditional biphasic counter anion
metathesis. Unlike the literature methods the column is left undisturbed after the
reaction and only 2 equivalents of the 125-225 equivalents of exchange salt
should have been used, enabling the columns to be reusable. In order to test this
hypothesis, we ran multiple counter anion metathesis reactions with varying
substrates using a single column as shown in Figure 57.
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Figure 57. Repeated use of a single sodium bromide exchange salt column
We demonstrated that one column can be used in multiple counter anion
metathesis reactions without a decrease in conversion or yield. Across the seven
trials the column maintained quantitative conversion to the desired bromide
counter anion and high yields. Between reaction 5 and 6 and 6 and 7 the column
was washed three times with 80 milliliters of dichloromethane to ensure that all of
the previous diaryliodonium salt had been washed off of the column, using this
procedure no cross contamination was noted in either reaction 6 or 7. There is a 6
week gap between reactions 6 and 7 where the column was stored in a lab cabinet
demonstrating that the columns are both reusable and shelf stable.
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This reaction does have some limitations, when the sodium triflate,
sodium tetrafluoroborate or sodium chloride were used the procedure maintained
high yields (>80%) but the conversion of the product was not synthetically useful
(<5% to 80%). The sodium trifluoroacetate (TFA) columns (98-101) suffered
from clogging issues where the columns flow rate would slow down and
sometimes stop over the course of a reaction. This issue can be alleviated by
admixing the exchange salt with an unreactive granular solid substance, sand an5d
celite are both common lab staples that work for this purpose. Our testing
determined that 0.25 grams of sand per mmol of sodium triflate alleviated this
issue and all triflate results in the scope table are reported using this methodology.
Another issue we faced was the solubility of certain diaryliodonium salts
in dichloromethane. The heterocyclic diaryliodonium salts 101 and 105 did not
fully dissolve in 20 milliliters of dichloromethane, in order to circumnavigate this
issue we used 20 milliliters of a solution of 5% methanol in 95% dichloromethane
to dissolve the diaryliodonium salt. This procure which resulted in a high
conversion and yield for both bromide and triflate counter anion metathesis.
5.1.3.2 Diaryliodonium salt counter anion metathesis conclusion
This procure presents an attractive methodology to access different
counter anions of diaryliodonium salts that is quick (>10 minutes), high yielding
(84% average), and is significantly more exchange salt efficient that comparative
literature methods by reusing shelf stable solid phase columns of exchange salt.
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These columns can be used across multinet diaryliodonium salts without cross
contamination and stored in ambient conditions for long periods of time.
5.1.4 Merck Safety Screen.
A common complaint of hypervalent iodine compounds is that the
compounds can pose a risk of explosion. Many well-known hypervalent iodine(V)
oxidizing agents such as Dess-Martin periodane (DMP) and 2-iodoxybenoic acid
(IBX) have been reported to be explosive.97 In order to allay these concerns for
diaryliodonium salts we partnered with Merck and co. to test the thermal stability
and explosivity of the diaryliodonium salts we work with.
A wide range of diaryliodonium salts were sent to Merck for differential
scanning calorimetry testing as shown in Figure 58. The majority of the
diaryliodonium salts tested did not undergo an exothermic decomposition event
until nearly 200 °C, well above standard operating temperatures for
diaryliodonium salts. (room temperature-77 °C) All entries tested were analyzed
by a Yoshida safety correlation, an analysis method that compares a compounds
exothermic event initiation temperatures and the exothermic energy generated by
those events and calculates the likelihood that the compound will be shock
sensitive (initiate an explosive event) and the likelihood that it will propagate an
explosive event. All diaryliodonium salts tested were found to be in the safe
region of the Yoshida correlation; they were unlikely to initiate or propagate an
explosive event. The most energetic of the compounds tested (paramethylester(TMB)trifuoroacetate) was subjected to a 25 Joule drop test and was
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found to be insensitive. These results lend strong evidence to the stability and
safety of diaryliodonium salts especially when operating in conditions below 100
°C.

Figure 58. differential scanning calorimetry testing of diaryliodonium salts
5.2 Otava Chemicals Inventory Management
Another collaboration that I participated in was our groups ongoing
business partnership with Otava Chemicals. The main goal of this business
partnership is to increase the availability and use of diaryliodonium salts by
making them commercially available. It is our hope that this will enable more
research groups to be able to use our chemistry in their research. Many metal
catalysis reactions require complex ligands and if those ligands were not
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commercially available it is likely that they would not see as much use as they
currently do.
My role as the diaryliodonium salt inventory manager is to maintain a
stock of diaryliodonium salts (>75) for chemical orders as well as synthesize any
other diaryliodonium salts requested for custom orders. I also perform
quantitative NMR analysis to ensure the purity of these compounds, package and
ship them to Clients. Listed below is an example order that was fulfilled in 2020. I
synthesized, analyzed, packaged, and shipped all compounds listed below in
under 3 weeks from when the order was placed.
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Figure 59. Example order placed through Otava Chemicals
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6. Conclusion
Substituted aryl compounds are an important structural motif in many
different industries. Diaryliodonium salts have gained notoriety as a metal free
arylation agent that proceed under mild conditions. In this work I have
demonstrated methodologies to synthesize diaryl ethers (Figure 20 and Figure 21)
in high yield under mild metal free conditions using aryl(TMP)tosylate
unsymmetric diaryliodonium salts. This reaction tolerates a wide range of
electronic and steric effects on both the aryl group (Figure 20) and the phenol
(Figure 21) coupling partner. This methodology also allows for the telescoping of
this reactivity directly from aryl iodides to the diaryl ether product in one pot.
(Figure 23) Novel highly sterically hindered ethers (Figure 25) and nonstandard
chemoselectivity of substituted pyridine (Figure 26) to synthesize products that
were desired in the literature. This methodology was also applied to aid in the
optimization of the synthesis of antimalarial drug Endochin-like quinolone 300
(Figure 34)
I have also developed a methodology to synthesize alkyl-aryl ethers using
unsymmetric aryl(TMP)tosylate diaryliodonium salts. This methodology was
compared to a wide range of literature methods including metal catalysis and
nucleophilic aromatic substitution (Figure 52) and was found to be competitive
(76% average yield) to the literature procedures (74% average yield) while using
metal free conditions, mild base, low temperatures and short reaction times. This
methodology also overcame a reported issue of competing reaction pathways
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when coupling alcohols with electron rich diaryliodonium salts that resulted in the
formation of arynes and meta regioisomers that are difficult to separate from the
product. It had also been reported that benzyl alcohols would undergo an
undesired oxidation pathway when reacted with diaryliodonium salts that resulted
in low yields and the formation of undesired aldehyde and ketone biproducts. The
conditions I developed tolerate benzyl alcohols and produce the desired products
in competitive yield (68% yield) when compared to other literature procedures
(66% yield)
I also developed an efficient methodology to perform counter anion
metathesis of diaryliodonium salts that makes more efficient use of the exchange
salt than literature procedures that require vast excess of the exchange salt (100
equivalents) by forming solid phase columns of exchange salt that are bench
stable and reusable.
The future work that will be performed on my projects is a mechanistic
study of alkyl-aryl ether synthesis via diaryliodonium salts. This project is
intended to elucidate the different parameters and characteristic of the aryl group
and alcohol that activate the three different reaction pathways present in the
synthesis: ipso substitution, aryne formation and alcohol oxidation. This work will
be carried out by Shubhendu Karandikar and once it is complete the alkyl-aryl
ether synthesis project will be published.
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Appendix A. Alkyl-aryl Ether Literature Sources
1. I3 2019: Reference number98
Pd 2017: Reference number99
Cu 2017: Reference number100
Ni 2019: Reference number 101
SNAr 2020: Reference number102
2. I3 2019: Reference number98
Cu 2017: Reference number100
3. I3 2019: Reference number98
Cu 2019: Reference number103
4. I3 2019: Reference number98
5. Unreported
6. Cu 2015: Reference number104
7. Cu 2011: Reference number105
SNAr 2020: Reference number102
8. Pd 1997: Reference number106
Ni 2019: Reference number101
SNAr 2020: Reference number102
9. I3 2015: Reference number33
Cu 2011: Reference number107
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10. I3 2014: Reference number18
Cu 2009: Reference number108
SNAr 2020: Reference number102
11. I3 2014: Reference number18
Pd 2015: Reference number109
Cu 2018: Reference number110
Co 2020: Reference number111
12. I3 2013: Reference number 19
Cu 2021: Reference number112
13. Cu 2021: Reference number112
14. SNAr 2005: Reference number113
15. I3 2015: Reference number33
16. Pd 2010: Reference number81
Cu 2016: Reference number114
Re 2005: Reference number115
17. Ni 2020: Reference number116
18. I3 2014: Reference number18
Cu 2021: Reference number112
SNAr 2020: Reference number102
19. I3 2014: Reference number18
Cu 2011: Reference number107
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20. Pd 2017: Reference number117
Ni 2020: Reference number116
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Appendix B. General Considerations
Commercially available reagents and solvents were used without further
purification unless otherwise stated. The percentage of active oxidant for mCPBA was determined by iodometric titration. Reactions performed above
ambient room temperature were done so in an oil bath or aluminum block heated
externally by a Heidolph MR Hei-Standard heating/stirring mantel equipped with
a Heidolph EKT HeiCON temperature control. Crude reaction mixtures were
analyzed by 1H NMR spectroscopy or thin-layer chromatography (TLC) on
Sigma-Aldrich TLC plates (silica gel 60 Å F-254) and visualized with a UV lamp.
Crude material was purified by flash column chromatography on SiliaFlash P60
silica gel, unless otherwise stated. 1H,

13

C{1H}, and

19

F{1H} spectra were

recorded in CDCl3, or DMSO-d6 (with tetramethylsilane as an internal standard)
on a Bruker Avance II 400 MHz spectrometer; the following notation issued: br –
broad, s – singlet, d – doublet, t – triplet, q – quartet, p – pentet, m – multiplet, dd
– doublet of doublets, dt – doublet of triplets, sext – sextet, setp – septet. FTIR
spectra were recorded on Thermo Scientific Nicolet iS5 Infra-red spectrometer.
High resolution mass spectrometry (HRMS) data were recorded on Thermo
Scientific LTQ Orbitrap Mass Spectrometer by electrospray ionization (ESI).
Melting points were recorded on Mel-Temp (Thermo scientific) and are reported
as uncorrected.
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Appendix C. General Procedure for Synthesis of Diaryliodonium Salts
General Procedure A:
Aryl iodide (5 mmol, 1 equiv.) and acetonitrile (5 mL) were added to a 50 mL
round bottom flask, equipped with a magnetic stir bar. p-Toluenesulfonic acid
(5.05 mmol, 1.01 equiv.) was added in one portion, followed by one portion of mCPBA (5.05 mmol, 1.01 equiv.). The reaction was stirred at 77 °C for 30 minutes.
After 30 minutes, 1,3,5-trimethoxybenzene (5.05 mmol, 1.01 equiv.) was added in
one portion and stirring was continued at 77 °C for 5 min. The reaction was
removed from heat and concentrated under reduced pressure. The crude residue
was triturated with diethyl ether. The precipitate was isolated by vacuum filtration
and washed with excess diethyl ether (3 × 20 mL). After drying under air for 15
minutes the diaryliodonium salt was obtained in analytically pure form. All
diaryliodonium salts will be labeled as S-X.
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S.1 Diaryl Ether Synthesis Supplementary Information
S.1.1 Diaryliodonium Salts Synthesized for Diaryl Ether Synthesis
Compound S-1:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 86% (2.39 g) as white solid. Spectral data is consistent with
that of previously reported.2b
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 7.76 (s, 1H), 7.70 (d, J=7.9 Hz, 1H),

7.47 (d, J=7.3 Hz, 2H), 7.42 (d, J=7.6 Hz, 1H), 7.34 (t, J=7.7 Hz, 1H), 7.10 (d,
J=7.5 Hz, 2H), 6.46 (s, 2H), 3.95 (s, 6H), 3.86 (s, 3H), 2.32 (s, 3H), 2.28 (s, 3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm),166.0, 159.3, 145.7, 141.3, 137.4,

134.4, 132.1, 131.3, 131.1, 127.9, 125.4, 115.8, 92.0, 86.8, 57.3, 56.0, 20.7, 20.6.
Compound S-2:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 82% (2.28 g) as white solid. Spectral data is consistent with
that of previously reported.
109

1H

NMR (400 MHz, DMSO-d6 δ (ppm), 8.05 (d, J=8.05 Hz, 1H), 7.52-7.51 (m,

2H), 7.46 (d, J=8.08 Hz, 2H), 7.25-7.20 (m, 1H), 7.10 (d, J=7.9 Hz, 2H), 6.44 (s,
2H), 3.95 (s, 6H), 3.85 (s, 3H), 2.60 (s, 3H), 2.28 (s, 3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 165.9, 159.2, 145.7, 140.3, 137.4,

137.0, 132.2, 131.0, 128.8, 127.9, 125.4, 121.2, 91.9, 86.5, 57.1, 56.0, 24.7, 20.7.
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Compound S-3:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 83% (2.39 g) as white solid.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 7.91 (d, J=8.7 Hz, 2H), 7.53 (d, J=8.7

Hz, 2H), 7.47 (d, J=8.0 Hz, 2H), 7.11 (d, J=7.9 Hz, 2H), 6.47 (s, 2H), 3.94 (s,
6H), 3.87 (s, 3H), 2.29 (s, 3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.2, 159.2, 145.7, 137.4, 136.6,

136.0, 131.4, 127.9, 125.4, 113.8, 92.0, 87.1, 57.3, 56.1, 20.7.
FTIR: 2940, 2922, 1580, 1179, 1117, 1031, 1007 cm -1
HRMS (ESI) m/z: [M – OTs]+ Calculated: 404.9749; Observed: 404.9735
Melting Point:205.8-208.2 oC
Compound S-4:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 87% (2.51 g) as white solid.
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1H

NMR (400 MHz, DMSO-d6 δ (ppm), 8.03 (t, J=1.8 Hz, 1H), 7.83 (d, J=8.1

Hz, 1H), 7.70-7.68 (m, 1H), 7.51-7.46 (m, 3H), 7.10 (d, J=8.0 Hz, 2H), 6.48 (s,
2H), 3.95 (s, 6H), 3.88 (s, 3H), 2.28 (s, 3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.3, 159.3, 145.7, 137.4, 134.5,

133.3, 132.9, 132.7, 131.6, 127.9, 125.4, 116.2, 92.0, 87.0, 57.3, 56.1, 20.7.
FTIR:2940, 2921, 1576, 1177, 1117, 1032, 1009 cm -1
HRMS (ESI) m/z: [M – OTs]+ Calculated: 404.9749; Observed: 404.9736
Melting Point:192.2-196.2 oC
Compound S-5:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 82% (2.36 g) as white solid.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 8.19 (d, J=8.0 Hz, 1H), 7.75 (d, J=8.0

Hz, 1H), 7.62 (t, J=7.7 Hz, 1H), 7.47 (d, J=7.3 Hz, 2H), 7.39 (t, J=7.6 Hz, 1H),
7.10 (d, J=7.5 Hz, 2H), 6.44 (d, 2H), 3.93 (s, 6H), 3.85 (s, 3H), 2.28 (s, 3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.1, 159.4, 145.6, 138.7, 137.5,

135.6, 133.8, 130.0, 129.6, 127.9, 125.4, 118.9, 91.9, 87.2, 57.1, 56.0, 20.7.
FTIR:2980, 2922, 1580, 1177, 1116, 1021, 1006 cm -1
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HRMS (ESI) m/z: [M – OTs]+ Calculated: 404.9749; Observed: 404.9736
Melting Point:115.5-156.5oC
Compound S-6:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 97% (2.72 g) as white solid.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 8.09 (t, J=6.9 Hz, 1H), 7.66 (q, J=7.0

Hz, 1H), 7.51 (d, J=8.4 Hz, 1H), 7.47 (d, J=7.6 Hz, 2H), 7.28 (t, J=7.6 Hz, 1H),
7.10 (d, J=7.6 Hz, 2H), 6.44 (s, 2H), 3.94 (s, 6H), 3.85 (s, 3H), 2.28 (s, 3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.1, 160.5, 159.3, 158.0, 145.7,

137.3 (d, J=36 Hz), 134.8 (d, J=8 Hz), 127.9, 127.2, 125.4,116.5 (d, J=22 Hz),
103.4 (d, J=24 Hz), 91.9, 87.3, 57.2, 56.0, 20.7.
19F {1H} NMR (376

MHz, DMSO-d6 δ (ppm), -97.9

FTIR:2980, 2948, 2865, 1581, 1175, 1117, 1022, 1007
HRMS (ESI) m/z: [M – OTs]+ Calculated: 389.0044; Observed: 389.0031
Melting Point:211.1-212.2 oC
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Compound S-7:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 95% (2.79 g) as an off-white solid. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 8.69 (t, J=1.9 Hz, 1H), 8.39 (dd, J1=8.2

Hz, J2=2.0 Hz, 1H), 8.25 (d, J=8.1 Hz, 1H), 7.75 (t, J=8.1 Hz, 1H), 7.46 (d, J=8.0
Hz, 2H), 7.10 (d, J=8.0 Hz, 2H), 6.50 (s, 2H), 3.96 (s, 6H), 3.88 (s, 3H), 2.28 (s,
3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.4, 159.4, 148.2, 145.5, 139.8,

137.6, 132.6, 128.4, 128.0, 126.1, 125.4, 115.7, 92.1, 87.1, 57.3, 56.2, 20.7.
Compound S-8:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 95% (2.73 g) as white solid.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 7.90 (dd, J1=6.9 Hz, J2= 1.9 Hz, 1H),

7.80-7.76 (m, 1H), 7.47 (d, J=8.1 Hz, 2H), 7.25 (t, J=9.2 Hz, 1H), 7.10 (d, J=7.9
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Hz, 2H), 6.46 (s, 2H), 3.95 (s, 6H), 3.87 (s, 3H), 2.28 (s, 3h), 2.25 (d, J=1.4 Hz,
3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.1, 162.2 (d, J=250 Hz), 159.2,

145.7, 137.6 (d, J=6 Hz), 137.4, 134.5 (d, J=8 Hz), 128.5 (d, J=18 Hz), 127.9,
125.4, 118.2 (d, J=23 Hz), 109.8 (d, J=3 Hz), 92.0, 87.2, 57.2, 56.1, 20.7, 13.91
(d, J=3Hz).
19F {1H} NMR (376

MHz, DMSO-d6 δ (ppm), -111.4

FTIR:2947, 2922, 2865, 2844, 1576, 1158, 1116, 1031 cm -1
HRMS (ESI) m/z: [M – OTs]+ Calculated: 403.0201; Observed: 403.0187
Melting Point:178.5-179.1oC
Compound S-9:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 75% (2.33 g) as yellow solid.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 8.51 (d, J=2.5 Hz, 1H), 8.44 (d, J=8.8

Hz, 1H), 8.14 (dd, J1=8.7 Hz, J2=2.5 Hz, 1H), 7.47 (d, J=8.0 Hz, 2H), 7.11 (d,
J=7.9 Hz, 2H), 6.46 (s, 2H), 3.94 (s, 6H), 3.86 (s, 3H), 2.29 (s, 3H)
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13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 165.3, 158.3, 149.0, 144.5, 138.6,

136.4, 135.8, 126.9, 124.6, 124.3, 123.5, 123.0, 91.0, 86.4, 56.1, 55.1, 19.6
FTIR: 3009, 2922, 1580, 1189, 1117, 1031 cm-1
HRMS (ESI) m/z: [M – OTs]+ Calculated: 449.9600; Observed: 449.9584
Melting Point:189.5-190.8 oC
Compound S-10:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 78% (2.28 g) as anoff-white solid. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 7.46 (d, J=8.0 Hz, 2H), 7.11-7.09 (m,

4H), 6.44 (s, 2H), 3.89 (s, 6H), 3.85 (s, 3H), 2.55 (s, 6H), 2.28 (s, 3H), 2.26 (s,
3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 165.7, 159.5, 145.7, 142.0, 141.6,

137.4, 129.2, 127.9, 125.4, 121.6, 92.1, 84.2, 56.9, 56.0, 25.6, 20.7, 20.3.
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Compound S-11:

Synthesized according to the general procedure A on 5 mmol scale and obtained
an isolated yield of 86% (2.45 g) as white solid.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 7.46 (d, J=8.1 Hz, 2H), 7.42-7.38 (m,

1H), 7.30 (d, J=7.4 Hz, 2H), 7.10 (d, J=7.9 H, 2H), 6.45 (s, 2H), 3.89 (s, 6H),
3.85 (s, 3H), 2.60 (s, 6H), 2.28 (s, 3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.8, 159.5, 145.7, 141.8, 137.4,

131.9, 128.5, 127.9, 125.4, 125.3, 92.1, 84.1, 56.9, 56.0, 25.8, 20.7.
FTIR:2980, 2940, 2922, 2855, 2843, 1583, 1174, 1115, 1010 cm -1
HRMS (ESI) m/z: [M – OTs]+ Calculated: 399.0452; Observed: 399.0433
Melting Point:148.1-150.3 oC
Compound S-12:

Synthesized according to the general procedure as an OTs salt (1a) on 5 mmol
scale, with a subsequent counter anion exchange reaction performed to give the
desired BF4 salt and obtained an isolated yield of 73% (1.72 g) as white solid.
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1H

NMR (400 MHz, DMSO-d6 δ (ppm), 7.80 (d, J=8.2 Hz, 2H), 7.27 (s, J=8.2

Hz, 2H), 6.45 (s, 2H), 3.94 (s, 6H), 3.86 (s, 3H), 2.32 (s, 3H)
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.0, 159.2, 141.9, 134.3, 132.1,

112.4, 91.9, 87.0, 57.2, 56.0, 20.7
19F {1H} NMR

(376 MHz, DMSO-d6 δ (ppm), 148.2, 148.3

FTIR:2981, 1578, 1214, 1050, 1033, 1005
HRMS (ESI) m/z: [M – OTs]+ Calculated: 385.0295; Observed: 385.0280
Melting Point:76.0-81.7 oC
Compound S-13:

Synthesized according to the general procedure as an OTs salt (1a) on 5 mmol
scale, with a subsequent counter anion exchange reaction performed to give the
desired OTf salt and obtained an isolated yield of 84% (2.24 g) as white solid. 2a
Spectral data is consistent with that of previously reported.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 7.80 (d, J=8.3 Hz, 2H), 7.27 (d, J=8.2

Hz, 2H), 6.45 (s, 2H), 3.94 (s, 6H), 3.86 (s, 3H), 2.32 (s, 3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 166.0, 159.2, 141.8, 134.3, 132.0,

120.6 (q, J=322 Hz), 112.4, 91.9, 87.0, 57.2, 56.0, 20.7
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Compound S-14:

4-iodo-toluene (2.5 mmols, 1 equiv.) was added to a vial along with 2.5 mL of
trifluoro ethanol, then m-CPBA (2.75 mmols, 1.1 equiv.), tosic acid (2.275
mmols, 1.1 eqiv) and toluene (5 mmols 2 eqiv) were added to the vial. The vial
was capped and stirred at 55 oC for 24 hours. The resulting organic solution was
dried over reduced pressure and triturated with diethyl ether and obtained an
isolated yield of 60% (1.44 g) as white solid. Spectral data is consistent with that
of previously reported.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 8.08 (d, J=8.3 Hz, 4H), 7.47 (d, J=8.0

Hz, 2H), 7.32 (d, J=8.3 Hz, 4H), 7.11 (d, J=7.9 Hz, 2H), 2.33 (s, 6H), 2.28 (s,
3H).
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 145.7, 142.3, 137.4, 134.9, 132.2,

127.9, 125.4, 113.0, 20.7, 20.7.
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S.1.2 1H, 13C{1H}, 19F{1H} NMR Spectra of Diaryliodonium Salts Synthesized
for Diaryl Ether Synthesis

Figure 60. 1H NMR of compound S-1 at 400 MHz in DMSO-d6 at 298 K

Figure 61. 13C{1H} NMR of compound S-1 at 101 MHz in DMSO-d6 at 298 K
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Figure 62. 1H NMR of compound S-2 at 400 MHz in DMSO-d6 at 298 K

Figure 63. 13C{1H} NMR of compound S-2 at 101 MHz in DMSO-d63 at 298 K
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Figure 64. 1H NMR of compound S-3 at 400 MHz in DMSO-d6 at 298 K

Figure 65. 13C{1H} NMR of compound S-3 at 101 MHz in DMSO-d6 at 298 K
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Figure 66. 1H NMR of compound S-4 at 400 MHz in DMSO-d6 at 298 K

Figure 67. 13C{1H} NMR of compound S-4 at 101 MHz in DMSO-d6 at 298 K
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Figure 68. 1H NMR of compound S-5 at 400 MHz in DMSO-d6 at 298 K

Figure 69. 13C{1H} NMR of compound S-5 at 101 MHz in DMSO-d6 at 298 K
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Figure 70. 1H NMR of compound S-6 at 400 MHz in DMSO-d6 at 298 K

Figure 71. 13C{1H} NMR of compound S-6 at 101 MHz in DMSO-d6 at 298 K
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Figure 72. 19F {1H} NMR of compound S-6 at 376 MHz in DMSO-d6 at 298 K
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Figure 73. 1H NMR of compound S-7 at 400 MHz in DMSO-d6 at 298 K

Figure 74. 13C{1H} NMR of compound S-7 at 101 MHz in DMSO-d6at 298 K
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Figure 75. 1H NMR of compound S-8 at 400 MHz in DMSO-d6at 298 K

Figure 76. 13C{1H} NMR of compound S-8 at 101 MHz in DMSO-d6 at 298 K
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Figure 77. 19F {1H} NMR of compound S-8 at 376 MHz in DMSO-d6at 298 K
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Figure 78. 1H NMR of compound S-9 at 400 MHz in DMSO-d6 at 298 K

Figure 79. 13C{1H} NMR of compound S-9 at 101 MHz in DMSO-d6 at 298 K
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Figure 80. 1H NMR of compound S-10 at 400 MHz in DMSO-d6at 298 K

Figure 81. 13C{1H} NMR of compound S-10 at 101 MHz in DMSO-d6at 298 K
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Figure 82. 1H NMR of compound S-11 at 400 MHz in DMSO-d6at 298 K

Figure 83. 13C{1H} NMR of compound S-11 at 101 MHz in DMSO-d6at 298 K
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Figure 84. 1H NMR of compound S-12 at 400 MHz in DMSO-d6at 298 K

Figure 85. 13C{1H} NMR of compound S-12 at 101 MHz in DMSO-d6at 298
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Figure 86. 19F{1H} NMR of compound S-12 at 376 MHz in CDCl3 at 298
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Figure 87. 1H NMR of compound S-13 at 400 MHz in DMSO-d6at 298 K

Figure 88. 13C{1H} NMR of compound S-13 at 101 MHz in DMSO-d6at 298 K
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Figure 89. 1H NMR of compound S-14 at 400 MHz in DMSO-d6at 298 K

Figure 90. 13C{1H} NMR of compound S-14 at 101 MHz in DMSO-d6at 298 K
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Appendix D. General Procedure for Synthesis of Diaryl Ethers
General Procedure B:
Iodonium salt (0.5 mmol, 1 equiv.), potassium carbonate (1.5 mmol, 3 equiv.),
phenol (0.55mmol, 1.1 equiv.), and toluene (2.5 mL) were added to an 8 mL vial,
equipped with a magnetic stir bar and sealed with a cap. The reaction was placed
in a preheated aluminum block set to 55 oC and stirred vigorously for 2 hours. The
reaction was removed from the block and partitioned between dichloromethane
and saturated aqueous ammonium chloride. The resulting organic solution was
evaporated

under

reduced

pressure

and

purified

using

flash

column

chromatography (0-3 % ethyl acetate: hexane). See below for specific scale of
reactions and characterization of data of individual compounds.
S.1.3 Synthesis of Diaryl Ethers
S.1.3.1 Diaryl Ether Synthesis Scope for Diaryliodonium Salts
Compound 1:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 91% (83.8 mg) as white solid. Spectral data is consistent with
that of previously reported.

137

1H

NMR (400 MHz, CDCl3) δ (ppm), 7.31-7.27 (m, 2H), 7.11 (d, J=8.4 Hz, 2H),

7.06-7.03 (m, 1H), 6.98-6.96 (m, 2H), 6.92-6.90 (m, 2H), 2.32 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 157.8, 154.7, 132.9, 130.2, 129.6,

122.8, 119.1, 118.3, 20.7
Compound 2:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 88% (81.0 mg) as white solid. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.32 (t J=7.8 Hz, 2H), 7.2 (t J=7.0 Hz,

1H), 7.08 (t J=8.0 Hz, 1H), 7.00 (d J=7.8, 2H) 6.91 (d J=7.5 1H), 6.83-6.80 (m, 2
H), 2.32 (s, 3H).
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 157.3, 157.2, 139.9, 129.7, 129.4,

124.0, 123.0, 119.6, 118.8, 115.9, 21.3
Compound 3:
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Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 91% (84.0 mg) as clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.29-7.21 (m 3H), 7.16-7.11 (m 1H), 7.06-

6.99 (m, 2H), 6.90-6.87 (m 3H), 2.23 (s 3H).
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 157.9, 154.4, 131.4, 129.9, 129.6,

127.1, 123.9, 122.3, 119.7, 117.2, 16.1
Compound 4:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 81% (82.9 mg) as clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.35-7.31 (m, 2H), 7.28-7.25 (m, 2H),

7.13-7.09 (m, 1H), 7.00-6.98 (m, 2H), 6.93-6.91 (m, 2H).
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 156.8, 155.9, 129.9, 129.7, 128.1,

123.6, 120.0, 118.9
Compound 5:
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Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 88% (90.1 mg) as clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.37-7.33 (m, 2H), 7.24-7.20 (m, 1H),

7.16-7.18 (m, 1H), 7.06-7.04 (m, 1H) 7.03-7.00 (m, 2H), 6.98 (t, J=2.1 Hz, 1H),
6.89-6.86 (m, 1H).
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 158.3, 156.3, 135.0, 130.4, 129.9,

123.9, 123.1, 119.4, 116.6
Compound 6:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 87% (89.0 mg) as white solid. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.44 (dd, J1=8.0 Hz, J2=1.6 Hz, 1H), 7.34-

7.30 (m, 2H), 7.20-7.18 (m, 1H), 7.11-7.06 (m, 2H), 6.98-6.94 (m, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 156.9, 152.5, 130.8, 129.8, 127.9,

125.9, 124.7, 123.3, 120.8, 117.9
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Compound 7:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 75% (70.6 mg) as clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.36-7.32 (m, 2H), 7.27-7.21 (m, 1H),

7.13-7.11 (m, 1H), 7.04-7.01 (m, 2H), 6.79-6.74 (m, 2H) 6.71-6.67 (m, 1H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 163.5 (d, J=247 Hz), 158.9 (d, J=10

Hz), 156.3, 130.5 (d, J=9 Hz), 129.9, 124.0, 119.5, 113.9(d, J=3 Hz), 109.8 (d,
J=20 Hz), 106.0 (d, J=25 Hz)
Compound 8:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 75% (70.5 mg) as clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.32-7.27 (m, 2H), 7.16-7.13 (m, 1H),

7.09-7.02 (m, 4H), 6.98-6.96 (m, 2H)
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13C {1H}

NMR (101 MHz, CDCl3) δ (ppm),157.3, 154.4 (d, J=249 Hz), 143.7 (d,

J=12 Hz), 129.7, 124.8 (d J=7 Hz), 124.6 (d, J=3 Hz), 123.1, 121.9 (d, J=3 Hz),
117.2, 117.1 (d, J=18 Hz)
Compound 9:

Synthesized according to the general procedure B on 0.5 mmol scale with a
reaction time of 24 hours and obtained an isolated yield of 85% (85.1 mg) as clear
oil. Spectral data is consistent with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.29 (t, J=7.8 Hz, 2H), 7.03 (t, J=7.3 Hz,

1H), 6.99-6.91 (m, 4H), 6.88 (d, J=9.0 Hz, 2H), 3.80 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),158.5, 155.8, 150.1, 129.6, 122.4,

120.8, 117.6, 114.8, 55.6
Compound 10:

Synthesized according to the general procedure B on 0.5 mmol scale with a
reaction time of 24 hours and obtained an isolated yield of 56% (56.0 mg) as
white solid. Spectral data is consistent with that of previously reported.
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1H

NMR (400 MHz, CDCl3) δ (ppm), 7.31-7.27 (m, 2H), 7.14-7.10 (m, 1H),

7.06-6.89 (m, 6H), 3.83 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),157.9, 151.5, 145.1, 129.5, 124.8,

122.4, 121.1, 121.1, 117.2, 112.8, 56.0
Compound 11:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 86% (92.5 mg) as clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.92 (d, J=8.2 Hz, 1H), 7.79-7.78 (m, 1H),

7.48 (t, J=8.2 Hz, 1H), 7.41 (t, J=7.3 Hz, 2H), 7.32 (d, J=8.2 Hz, 1H), 7.22 (t,
J=7.4 Hz, 1H), 7.06 (d, J=7.9 Hz, 2H).
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),158.6, 155.5, 149.3, 130.3, 130.3,

124.9, 124.1, 119.8, 117.6, 112.8
Compound 12:
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Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 77% (94.8 mg) as white solid. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.53-7.49 (m, 4H), 7.39-7.56 (m, 2H),

7.29-7.28 (m, 3H), 7.09-7.02 (m, 5H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),157.0, 156.7, 140.4, 136.1, 129.7,

128.7, 128.3, 126.9, 126.8, 123.3, 119.0, 118.9
Compound 13:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 91% (93.6 mg) as colorless oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.15 (m, 1H), 7.40-7.36 (m, 2H), 7.26 (d -

J=1.8 MHz 2H), 7.19-7.15 (m, 1H), 7.03-7.01 (m, 2H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),155.9, 153.2, 144.7, 140.5, 130.1,

128.4, 124.7, 128.4, 119.0
Compound 14:
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Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 84% (84.9 mg) as clear oil.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.29 (t, J=7.9 Hz, 2H), 7.04 (t, J=7.4 Hz,

1H), 6.95-6.91 (m, 3H), 6.84-6.82 (m, 1H), 6.79-6.75 (m, 1H), 2.22 (3H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 157.8, 157.5 (d, J=240 Hz), 152.4 (d,

J=3 Hz),129.7, 126.2 (d, J=19 Hz), 122.9, 122.0 (d, J=5 Hz), 118.1, 117.8 (d, J=9
Hz), 115.7 (d, J=24 Hz), 14.6 (d, J=3 Hz)
FTIR: 3040, 2926, 1587, 1104, 1071, 1022 cm -1
GCMS m/z: [M] Calculated: C13H11FO: 202.1, Observed: 202.1
Compound 15:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 73% (91.1 mg) as colorless oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.38 (d, J=2.3 Hz, 1H), 8.04 (dd, J1=9.1 Hz

J2=2.6 Hz, 1H), 7.45 (t, J=7.9 Hz, 2H), 7.28 (t, J=7.4 Hz, 1H), 7.09 (d, J=8.2 Hz,
2H), 6.87 (d, J=9.1 Hz, 1H)
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13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 159.0, 154.5, 142.6, 130.4, 126.5,

125.7, 124.6, 123., 120.19, 116.7
Compound 16:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 84% (89.2 mg) as colorless oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.23 (t, J=7.4 Hz, 2H), 6.94 (t, J=7.3 Hz,

1H), 6.89 (s, 2h), 6.75 (d, J=7.9 Hz, 2H), 2.29 (s, 3H), 2.07 (s, 6H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),158.0, 148.8, 134.4, 131.1, 129.6,

129.5, 121.1, 114.6, 20.8, 16.2
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Figure 91. 1H NMR of compound 1 at 400 MHz in CDCl3 at 298 K

Figure 92. 13C{1H} NMR of compound 1 at 101 MHz in CDCl3 at 298 K
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Figure 93. 1H NMR of compound 2 at 400 MHz in CDCl3 at 298 K

Figure 94. 13C{1H} NMR of compound 2 at 101 MHz in CDCl3 at 298 K
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Figure 95. 1H NMR of compound 3 at 400 MHz in CDCl3 at 298 K

Figure 96. 13C{1H} NMR of compound 3 at 101 MHz in CDCl3 at 298 K
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Figure 97. 1H NMR of compound 4 at 400 MHz in CDCl3 at 298 K

Figure 98. 13C{1H} NMR of compound 4 at 101 MHz in CDCl3 at 298 K
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Figure 99. 1H NMR of compound 5 at 400 MHz in CDCl3 at 298 K

Figure 100. 13C{1H} NMR of compound 5 at 101 MHz in CDCl3 at 298 K
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Figure 101. 1H NMR of compound 6 at 400 MHz in CDCl3 at 298 K

Figure 102. 13C{1H} NMR of compound 6 at 101 MHz in CDCl3 at 298 K
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Figure 103. 1H NMR of compound 7 at 400 MHz in CDCl3 at 298 K

Figure 104. 13C{1H} NMR of compound 7 at 101 MHz in CDCl3 at 298 K
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Figure 105. 1H NMR of compound 8 at 400 MHz in CDCl3 at 298 K

Figure 106. 13C{1H} NMR of compound 8 at 101 MHz in CDCl3 at 298 K
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Figure 107. 1H NMR of compound 9 at 400 MHz in CDCl3 at 298 K

Figure 108. 13C{1H} NMR of compound 9 at 101 MHz in CDCl3 at 298 K
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Figure 109. 1H NMR of compound 10 at 400 MHz in CDCl3 at 298 K

Figure 110. 13C{1H} NMR of compound 10 at 101 MHz in CDCl3 at 298 K
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Figure 111. 1H NMR of compound 11 at 400 MHz in CDCl3 at 298 K

Figure 112. 13C{1H} NMR of compound 11 at 101 MHz in CDCl3 at 298 K
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Figure 113. 1H NMR of compound 12 at 400 MHz in CDCl3 at 298 K

Figure 114. 13C{1H} NMR of compound 12 at 101 MHz in CDCl3 at 298 K
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Figure 115. 1H NMR of compound 13 at 400 MHz in CDCl3 at 298 K

Figure 116. 13C{1H} NMR of compound 13 at 101 MHz in CDCl3 at 298 K
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Figure 117. 1H NMR of compound 14 at 400 MHz in CDCl3 at 298 K

Figure 118. 13C{1H} NMR of compound 14 at 101 MHz in CDCl3 at 298 K
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Figure 119. 1H NMR of compound 15 at 400 MHz in CDCl3 at 298 K

Figure 120. 13C{1H} NMR of compound 15 at 101 MHz in CDCl3 at 298 K
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Figure 121. 1H NMR of compound 16 at 400 MHz in CDCl3 at 298 K

Figure 122. 13C{1H} NMR of compound 16 at 101 MHz in CDCl3 at 298 K
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S1.3.4 Diaryl Ether Synthesis Scope for Phenols
Compound 17:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 84% (101.7 mg) as colorless oil. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.99-7.96 (m, 2H), 7.27 (d, J=7.4 Hz, 1H),

7.21 (t, J=7.2 Hz, 1H), 7.13 (t, J=7.3 Hz, 1H), 6.98-6.96 (m, 1H), 6.88-6.85 (m,
2H), 3.87 (s, 3H), 2.18 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),166.6, 162.1, 153.1, 131.7, 130.5,

127.5, 125.1, 123.8, 120.9, 115.9, 51.9, 16.0. One additional peak not seen due to
peak overlap (aromatic region)
Compound 18:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 88% (108.3 mg) as colorless oil. Spectral data is consistent
with that of previously reported.
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1H

NMR (400 MHz, CDCl3) δ (ppm), 8.01-7.99 (m, 2H), 7.10-7.01 (m, 4H),

6.96-6.93 (m, 2H), 3.90 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),166.5, 162.0, 159.5 (d, J=243 Hz),

151.3 (d, J=6 Hz), 131.7, 124.5, 121.7 (d, J=8 Hz), 116.8, 116.7 (d, J=23 Hz),
52.0
Compound 19:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 95% (104.8 mg) as colorless oil. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.00 (d, J=8.8 Hz, 2H), 7.38 (t, J=8.6 Hz,

2H) 7.18 (t, J=7.4 Hz, 1H), 7.06 (d, J=7.8 Hz, 2H), 6.98 (d, J=8.8 Hz, 2H), 3.89
(s, 3H).
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),166.6, 161.8, 155.6, 131.7, 130.0,

124.4(9), 124.4(7), 120.1, 117.3, 52.0
Compound 20:
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Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 95% (120.3 mg) as colorless oil. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.07(d, J=8.0 Hz, 2H), 7.51-7.45 (m, 2H),

7.30 (d, J=9.4 Hz, 2H), 7.03 (d, J=8.1 Hz, 2H), 3.92 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),166.3, 160.2, 156.6, 132.1, 132.0,

127.7, 126.0, 124.0, 122.6, 118.3, 117.9, 113.8, 52.2
Compound 21:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 87% (128.9 mg) as colorless oil. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.05 (d, J=8.7 Hz, 2H), 7.62 (d, J=8.7 Hz,

2H), 7.11 (d J=8.6 Hz, 2H), 7.04 (d, J=8.7 Hz, 2H), 3.90 (s, 3H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 166.4, 160.3, 159.0, 132.0, 127.5 (q,

J=3 Hz), 126.2 (q, J=33 Hz), 125.9, 124.1 (q, J=272 Hz), 119.3, 118.5, 52.1.
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Compound 22:

Synthesized according to the general procedure B on 0.5 mmol scale and a
reaction time of 24 hours and obtained an isolated yield of 70% (89.7 mg) as clear
oil. When the reaction was ran for 72 hours an 82% (105.1 mg) yield was
obtained. Spectral data is consistent with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.96 (d, J=7.8Hz, 2H), 7.10 (m, 3H), 6.78

(d, J=7.8 Hz, 2H), 3.87 (s, 3H), 2.10 (s, 6H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 166.7, 161.6, 150.6, 131.8, 131.2,

129.1, 125.5, 123.4, 114.4, 51.9, 16.2
Compound 23:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 75% (145.7 mg) as white solid.
Melting Point:67.3-68.0oC
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1H

NMR (400 MHz, CDCl3) δ (ppm), 8.03 (d, J=8.8 Hz, 2H), 7.53 (s, 1H), 7.42

(d, J=9.2 Hz, 1H), 7.00-6.98 (m, 3H), 3.90 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),166.3, 160.6, 154.4, 134.0, 131.8,

131.1, 129.9, 125.5, 120.8, 117.7, 98.3, 52.1
FTIR:3067, 3052, 2959, 1708, 1503, 1106, 1018 cm -1
HRMS (ESI) m/z: [M + H]+ Calculated: C14H11ClIO3+: 388.9436; Observed:
388.9427
Compound 24:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 86% (112.9 mg) as white solid. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.01 (d, J=8.8 Hz, 2H), 7.34 (d, J=8.8 Hz,

2H), 6.98 (t, J=8.3 Hz, 4H), 3.90 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),166.5, 161.3, 154.3, 131.8, 130.1,

129.6, 124.9, 121.3, 117.4, 52.0
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Compound 24:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 86% (132.1 mg) as white solid. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.01 (d, J=8.9 Hz, 2H), 7.49 (d, J=8.9 Hz,

2H), 6.96 (dd, J=8.9 Hz, 4H), 3.90 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 166.5, 161.2, 154.9, 133.0, 131.8,

125.0, 121.7, 127.5, 117.1, 52.1
Compound 26:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 79% (101.2 mg) as white solid. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 9.96 (s, 1H), 8.08 (d, J=8.7 Hz, 2H), 7.90

(d, J=8.6, 2H), 7.14 (d, J=8.6 Hz, 2H), 7.10 (d, J=8.7 Hz, 2H), 3.92 (s, 3H)
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13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),190.7, 166.3, 161.6, 159.6, 132.2,

132.0, 131.9, 126.3, 119.1, 118.9, 52.2
Compound 27:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 76% (105.8 mg) as clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.03-8.00 (m, 2H), 7.84 (t, J=8.8 Hz, 2H),

7.72 (d, J=7.8 Hz, 1H), 7.49-7.41 (m, 3H), 7.23 (dd, J1=8.8 Hz, J2=2.4 Hz, 1H),
7.04-7.01 (m, 2H), 3.89 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm),166.6, 161.7, 153.3, 132.2, 131.7,

130.7, 130.2, 127.8, 127.3, 126.7, 125.3, 124.7, 120.3, 117.5, 116.1, 52.0

Compound 28:
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Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 93% (132.7 mg) as a clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, DMSO-d6 δ (ppm), 10.03 (s, 1H), 7.96-7.94 (m, 2H), 7.67

(d, J=8.9 Hz, 2H), 7.10-7.08 (m, 2H), 7.02-7.00 (m, 2H), 3.83 (s, 3H), 2.06 (s,
3H)
13C {1H}

NMR (101 MHz, DMSO-d6 δ (ppm), 167.6, 165.1, 161.4, 149.2, 135.8,

130.9, 123.0, 120.1, 116.0, 51.4, 23.3. One additional peak not seen due to
overlap (120.1)
Compound 29:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 61% (172.3 mg) as a mixture of diastereomers as yellow oil.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.94 (dd, J1= 8.5 Hz, J2= 2.1 Hz, 2H),

7.27-7.25 (m, 2 H), 3.88 (s, 3H), 2.10 (s, 3H), 1.84-0.84 (m, 46H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 201.7, 166.9, 148.3, 142.9, 129.9,

128.5, 128.1, 126.9, 117.3, 75.7, 55.1, 52.0, 40.7, 39.4, 38.9, 37.4, 32.8, 31.6,
31.0, 28.0, 24.8, 24.4, 24.3, 23.2, 23.0, 22.8, 22.7, 22.6, 20.9, 20.8, 19.7, 19.6,
19.4, 19.3, 14.5, 14.1, 11.5
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FTIR: 2949, 2923, 2866, 2845, 1723, 1590, 1110, 1090, 1055, 1018 cm -1
HRMS (ESI) m/z: [M + H]+ Calculated: C37H57O4+: 565.4251; Observed:
565.4259
Compound 30:

Synthesized according to the general procedure B on 0.5 mmol scale and obtained
an isolated yield of 68% (137.5 mg) as white solid.
Melting Point:195.2-197.5 oC
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.99 (d, J=7.8 Hz, 2H), 7.29 (d, J=8.4 Hz,

1H), 6.98 (d, J=7.8 Hz, 2h), 6.84 (d, J=8.5 Hz, 1H), 6.80 (s, 1H), 3.89 (s, 3H),
2.90-2.88 (m, 2H), 2.55-1.97 (m, 7h), 1.67-1.46 (m, 6H), 0.94 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 166.7, 162.1, 153.4, 138.6, 136.1,

131.6, 126.9, 124.2, 120.2, 117.5, 117.1, 52.0, 50.4, 48.0, 44.1, 38.1, 35.9, 31.6,
29.5, 26.4, 25.8, 21.6, 13.9. another peak not seen due to peak overap. (aromatic
region)
FTIR: 3067, 2959, 2871, 2843, 1708, 1503, 1107, 1053, 1033 cm -1
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HRMS (ESI) m/z: [M + H]+ Calculated: C26H29O4+: 405.2060; Observed:
405.2054
[M + Na]+ Calculated: C26H28NaO4+: 427.1880; Observed:
427.1875
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Figure 123. 1H NMR of compound 17 at 400 MHz in CDCl3 at 298 K

Figure 124. 13C{1H} NMR of compound 17 at 101 MHz in CDCl3 at 298 K
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Figure 125. 1H NMR of compound 18 at 400 MHz in CDCl3 at 298 K

Figure 126. 13C{1H} NMR of compound 18 at 101 MHz in CDCl3 at 298 K
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Figure 127. 1H NMR of compound 19 at 400 MHz in CDCl3 at 298 K

Figure 128. 13C{1H} NMR of compound 19 at 101 MHz in CDCl3 at 298 K
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Figure 129. 1H NMR of compound 20 at 400 MHz in CDCl3 at 298 K

Figure 130. 13C{1H} NMR of compound 20 at 101 MHz in CDCl3 at 298 K
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Figure 131. 1H NMR of compound 21 at 400 MHz in CDCl3 at 298 K

Figure 132. 13C{1H} NMR of compound 21 at 101 MHz in CDCl3 at 298 K
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Figure 133. 1H NMR of compound 22 at 400 MHz in CDCl3 at 298 K

Figure 134. 13C{1H} NMR of compound 22 at 101 MHz in CDCl3 at 298 K
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Figure 135. 1H NMR of compound 23 at 400 MHz in CDCl3 at 298 K

Figure 136. 13C{1H} NMR of compound 23 at 101 MHz in CDCl3 at 298 K
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Figure 137. 1H NMR of compound 24 at 400 MHz in CDCl3 at 298 K

Figure 138. 13C{1H} NMR of compound 24 at 101 MHz in CDCl3 at 298 K
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Figure 139. 1H NMR of compound 25 at 400 MHz in CDCl3 at 298 K

Figure 140. 13C{1H} NMR of compound 25 at 101 MHz in CDCl3 at 298 K
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Figure 141. 1H NMR of compound 26 at 400 MHz in CDCl3 at 298 K

Figure 142. 13C{1H} NMR of compound 26 at 101 MHz in CDCl3 at 298 K
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Figure 143. 1H NMR of compound 27 at 400 MHz in CDCl3 at 298 K

Figure 144. 13C{1H} NMR of compound 27 at 101 MHz in CDCl3 at 298 K

183

Figure 145. 1H NMR of compound 28 at 400 MHz in DMSO-d6 at 298 K

Figure 146. 13C{1H} NMR of compound 28 at 101 MHz in DMSO-d6 at 298 Ke

184

Figure 147. 1H NMR of compound 29 at 400 MHz in CDCl3 at 298 K

Figure 148. 13C{1H} NMR of compound 29 at 101 MHz in CDCl3 at 298 K
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Figure 149. 1H NMR of compound 30 at 400 MHz in CDCl3 at 298 K

Figure 150. 13C{1H} NMR of compound 30 at 101 MHz in CDCl3 at 298 K
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S.1.3.6 Synthesis of Highly Sterically Hindered 2,2’,6,6’-tetramethyldiphenyl
ether
Compound 36:

Iodonium salt S-11 (0.5 mmol, 1 equiv.), potassium carbonate (1.5 mmol, 3
equiv.), phenol (0.55mmol, 1.1 equiv.), and toluene (2.5 mL) were added to an 8
mL vial, equipped with a magnetic stir bar and sealed with a cap. The reaction
was placed in a preheated aluminum block set to 80oC and stirred vigorously for
24 hours. The reaction was removed from heat and partitioned between
dichloromethane and saturated aqueous ammonium chloride. The resulting
organic solution was evaporated under reduced pressure and purified using flash
column chromatography (2 % ethyl acetate: hexane). The desired product was
obtained an isolated yield of 52% (58.8 mg) as white solid.
Melting Point:48.1-50.1 oC
1H

NMR (400 MHz, CDCl3) δ (ppm), 6.96 (d, J=7.4 Hz, 4H), 6.90-6.86 (m, 2H),

2.04 (s, 12H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 154.2. 129.3, 128.1, 122.6, 17.3

FTIR:2956, 2921, 2864, 2842, 1503, 1032, 1017 cm -1
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HRMS (ESI) m/z: [M + H]+ Calculated: C16H18O+: 227.1430; Observed:
224.1425
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Figure 151. 1H NMR of compound 36 at 400 MHz in CDCl3 at 298 K

Figure 152. 13C{1H} NMR of compound 36 at 101 MHz in CDCl3 at 298 Ke
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Appendix E. General Procedure for Telescoped Synthesis of Diaryl Ethers
General procedure C:
Aryl iodide (0.5 mmols, 1 equiv.) and acetonitrile (0.5 mL) were added to an 8
mL vial equipped with a magnetic stir bar. p-Toluenesulfonic acid (0.55 mmols,
1.1 equiv.) was added in one portion, followed by one portion of m-CPBA (0.55
mmols, 1.1 equiv.). The vial was sealed with a cap and transferred to a preheated
aluminum block set to 55 oC and stirred vigorously, after 30 minutes 1,3,5trimethoxybenze (0.5 mmols, 1.0 equiv.) was added in one portion and stirring
was continued at 55 oC for 10 minutes. Then toluene (2.5 mL) was added to the
vial, followed by potassium carbonate (2.0 mmol, 4 equiv.) and phenol (2a, 2l,
2n) (0.55 mmol, 1.1 equiv.). The reaction was stirred at 55 oC for 2 hours. The
reaction was removed from heat and partitioned between dichloromethane and
saturated aqueous ammonium chloride. The resulting organic solution was
evaporated

under

reduced

pressure

and

purified

using

flash

column

chromatography (0-3 % ethyl acetate: hexane). See below for specific scale of
reactions and characterization of data of individual compounds.
S.1.4 Telescoped One-Pot Diaryl Ether Synthesis from Aryl Iodides
Compound 26:
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Synthesized according to the general procedure C on 0.5 mmol scale and obtained
an isolated yield of 60% (76.9 mg) as white solid. Spectral data is consistent with
that of previously reported.
Compound 20:

Synthesized according to the general procedure C on 0.5 mmol scale and obtained
an isolated yield of 78% (98.8 mg) as white solid. Spectral data is consistent with
that of previously reported.
Compound 23:

Synthesized according to the general procedure C on 1 mmol scale and obtained
an isolated yield of 85% (330.3 mg) as white solid. Spectral data is consistent
with compound 23.
Compound 31:
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Synthesized according to the general procedure C on 0.5 mmol scale and obtained
an isolated yield of 68% (147.2 mg) as yellow oil.
1H

NMR(400 MHz, CDCl3) δ (ppm), 7.99 (d, J=8.9 Hz, 2H), 7.29 (d, J=8.5 Hz,

1H), 6.98 (d, J=8.9 Hz, 2H), 6.86-6.83 (m, 1H), 6.80-6.79 (m, 1H), 3.90 (s, 3h),
2.92-2.88 (m, 2h), 2.552.49 (m, 1H), 2.44-2.40 (m, 1H), 2.31-2.30 (m, 1H), 2.182.96 (m, 5H), 1.66-1.46 (m, 7H), 0.94 (s, 3H)
13C{1H}

NMR (101 MHz, CDCl3) δ (ppm), 154.6, 152.0, 133.8, 131.7, 130.9,

130.6, 130.0, 129.3, 122.1 (q, J=16 Hz), 118.9, 117.8 (d, J=16 Hz), 98.4
FTIR: 3066, 1573, 1075, 1017 cm-1
GCMS: m/z: [M] Calculated: C13H6F3IO: 432.0, Observed: 431.9
Compound 32:

Synthesized according to the general procedure C on 0.5 mmol scale and obtained
an isolated yield of 56% (107.7 mg) as colorless oil. The starting iodide was
recovered in 36% yield.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.99-7.97 (m, 2H), 7.40 (d, J=8.7 Hz, 1H),

6.99-6.92 (m, 4H), 6.87-6.86 (m, 2H), 6.63 (dd, J1=7.4 MHz, J2=4.0 MHz, 1H),
6.57 (d, J=1.8 Hz, 1H), 3.88 (s, 3H), 3.77 (s, 3H)

192

13C{1H}

NMR (101 MHz, CDCl3) δ (ppm),166.4, 161.0, 156.4, 155.2, 155.0,

149.1, 131.7, 131.2, 125.0, 120.5, 119.7, 115.0, 114.6, 110.3, 55.6, 52.0
FTIR: 2921, 2864, 1711, 1503, 1056 cm-1
HRMS (ESI) m/z:

[M

+ H]+ Calculated: C21H18ClO5+: 385.0837; Observed:

[M

+

385.0829
Na]+

Calculated:

C21H17ClNaO5+:

407.0657;

Observed: 407.0651
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Figure 153. 1H NMR of compound 31 at 400 MHz in CDCl3 at 298 K

Figure 154. 13C{1H} NMR of compound 31 at 101 MHz in CDCl3 at 298 K
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Figure 155. 1H NMR of compound 32 at 400 MHz in CDCl3 at 298 K

Figure 156. 13C{1H} NMR of compound 32 at 101 MHz in CDCl3 at 298 K
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S.1.4.2 Telescoped Synthesis of Substituted Pyridine from Aryl Iodides via
Diaryliodonium Salts
Compound 35:

2-chloro-5-iodopyridine (0.5 mmols, 1 equiv.) and acetonitrile (0.5 mL) were
added to an 8 mL vial equipped with a magnetic stir bar. p-Toluenesulfonic acid
(0.55 mmols, 1.1 equiv.) was added in one portion, followed by one portion of mCPBA (0.55 mmols, 1.1 equiv.). The vial was sealed with a cap and transferred to
a preheated aluminum block set to 55 oC and stirred vigorously, after 30 minutes
trimethoxybenze (0.5 mmols, 1.0 equiv.) was added in one portion and stirring
was continued at 55 oC for 10 minutes. Then toluene (2.5 mL) was added to the
vial, followed by potassium carbonate (2.0 mmol, 4 equiv.) and 4-chloro-2methoxyphenol (0.55 mmol, 1.1 equiv.). The reaction was stirred at 55 oC for 2
hours. The reaction was removed from heat and partitioned between
dichloromethane and saturated sodium hydroxide. The resulting organic solution
was evaporated under reduced pressure and purified using flash column
chromatography (2:10:88 diehtylether : toluene : hexane) and obtained an isolated
yield of 65% (88.1 mg) with 5% 2,4,6-trimethoxyphenyliodide (TMP-I) as white
solid.
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1H

NMR (400 MHz, CDCl3) δ (ppm), 8.05 (d, J=2.9 Hz, 1H), 7.23-7.21 (m, 1H),

7.16-7.13 (m, 1H), 7.0-6.93 (m, 3H), 3.79 (s, 3H)
13C{1H} NMR

(101 MHz, CDCl3) δ (ppm), 153.6, 151.8, 144.1, 142.0, 138.6,

131.2, 126.4, 124.5, 122.4, 121.1, 113.6, 56.1
FTIR: 3068, 3000, 2975, 2941, 1572, 1177, 1116, 1020 cm -1
HRMS: (ESI) m/z: [M + H]+ Calculated: C12H10Cl2NO2 + : 270.0083; Observed:
270.0078
Melting Point: 48.1-49.7 °C
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S.1.4.3 1H, 13C{1H}, 19F{1H} NMR Spectra of Telescoped Synthesis of
Substituted Pyridine from Aryl Iodides via Diaryliodonium Salts

Figure 157. 1H NMR of compound 35 at 400 MHz in DMSO-d6 at 298 K

Figure 158. 13C{1H} NMR of compound 35 at 101 MHz in DMSO-d6 at 298 K
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S.2 Synthesis of Anti-Malarial ELQ 300
S.2.1 Synthesis of Diaryliodonium Salts for Synthesis of Anti-Malarial ELQ
300
Compound 52:

1H

NMR (600 MHz, [D6] DMSO) δ 8.03 (d, J=8.7 Hz, 2 H), 7.47 (m, 4 H), 7.10

(d, J=7.8 Hz, 2H), 6.48 (s, 2H), 3.95 (s, 6H), 3.87 (S, 3H), 2.28 (s, 3H)
13C{1H} NMR

(101 MHz, [D6] DMSO) δ 166.8, 159.8, 150.7, 146.1, 138.1, 137.2,

128.9, 125.9, 124.3, 120.3 (q, J=171.2 Hz) 114.2, 92.6, 87.7, 57.8, 56.6, 21.2
FTIR (cm-1) 3054, 2984, 2945, 2845, 1581, 1263, 1228, 1161, 1121, 1031, 1008,
816, 732, 702
HRMS (ESI) m/z: [M – OTs]+ Calculated: 454.9962; Observed: 454.9959
Melting Point: 190-192 oC
Aryl iodide (62 mL, 1 equiv.) was added to a room temperature round bottom
flask containing acetonitrile (384 mL) and tosic acid (73.04 g, 1.1 equiv.).
mCPBA (97.84 g, 1.1 equiv.) was then added slowly to the flask which was then
lowered into a preheated oil bath and stirred for 40 minutes. A yellow slurry will
begin to develop as the reaction progresses. After 40 minutes the
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trimethoxybezene (64.58 g, 1.0 equiv.) was added to the flask and the slurry
dissolves into an orange liquid. The reaction was removed from heat and cooled
to room temperature. The solution was triturated with diethyl ether and filtered
resulting in 205.3 g (85% yield) of yellow solid.
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S.2.2 1H, 13C{1H}, 19F{1H} NMR Spectra of Diaryliodonium Salts for
Synthesis of Anti-Malarial ELQ 300

Figure 159. 1H NMR of compound 52 at 400 MHz in CDCl3 at 298 K

Figure 160. 13C{1H} NMR of compound 97 at 101 MHz in CDCl3 at 298 K
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S.2.3 Published ELQ 300 Diary Ether Fragment Synthesis
Compound 56:

1H

NMR (600 MHz, [D6] DMSO) δ 7.27 (d, J=8.8 Hz, 2H), 7.17 (d, J=8.6, 2H),

6.98 (m, 4H) 4.17 (q, J=7.1 Hz, 2H), 1.27 (t, J=7.1 Hz, 3H)
13C{1H} NMR

(101 MHz, [D6] DMSO) δ 171.6, 155.9, 155.8, 130.8, 129.6, 122.6,

121.4 119.5, 119.1, 60.9, 40.6, 14.2 CF3 indistinguishable from noise
FTIR (cm-1) 3054, 2986, 1732, 1498, 1264, 1241, 1206, 1188, 1162, 1101, 1030,
1015, 736, 704
HRMS (ESI) m/z: [M + H]+ Calculated: 341.0956; Observed: 341.0996
Iodonium salt (0.31 g, 1.0 equiv.) was added to a room temperature round bottom
flask containing toluene (1.25 mL) and potassium carbonate (0.207 g, 3.0 equiv.).
Ethyl 4-hydroxyphenyl acetate (0.12 mL, 1.5 eq) was added to the flask and it
was placed in a preheated oil bath and stirred for 2.5 hours. The solution was
removed from heat and concentrated under vacuum. The resulting brown oil was
purified via a short column using 5% ethyl ether in hexanes resulting in 0.1423 g
of a yellow oil (the product) mixed with a white solid (TMBI) (Yield by NMR
was ~54% (~0.075 g) for 0.5 mmol and ~43% (~0.51 g) for 3.6 mmol).
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S.2.4 1H, 13C{1H}, 19F{1H} NMR Spectra of Published ELQ 300 Diary Ether
Fragment Synthesis

Figure 161. 1H NMR of compound 56 at 400 MHz in CDCl3 at 298 K

Figure 162. 13C{1H} NMR of compound 56 at 101 MHz in CDCl3 at 298 K
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Appendix F. General Procedure for Alkyl-Aryl Ether Synthesis
General Procedure D:
Iodonium salt (0.5 mmol, 1 equiv.), cesium carbonate (1.5 mmol, 3 equiv.),
alcohol (0.75mmol, 1.5 equiv.), and toluene (2.5 mL) were added to an 8 mL vial,
equipped with a magnetic stir bar and sealed with a cap. The reaction was placed
in a preheated aluminum block set to 55 oC and stirred vigorously for 2 hours. The
reaction was removed from the block and partitioned between dichloromethane
and saturated aqueous ammonium chloride. The resulting organic solution was
evaporated

under

reduced

pressure

and

purified

using

flash

column

chromatography (0-3 % ethyl acetate: hexane).
S.3 Alkyl-Aryl Ether Synthesis
Compound 78:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 96% (96.1 mg) as a white solid. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.65 (d, J=8.9 Hz, 2H), 7.02 (d, J=8.9 Hz,

2H), 4.42 (q, J=7.9 Hz, 2H)
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13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 160.3, 134.3, 122.9 (q, J=277.9 Hz),

118.6, 115.6, 106.2, 65.6 (q, J=36.3 Hz)
Compound 79:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 70% (89.8 mg) as an off-white solid. Spectral data is
consistent with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.41 (d, J=8.9 Hz, 2H), 6.82 (d, J=8.9 Hz,

2H), 4.31 (q, J=8.1 Hz, 2H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 156.5, 132.6, 123.2 (q, J=278.1 Hz),

116.8, 115.0, 66.0, (q, J=35.8 Hz)
Compound 80:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 88% (110.6 mg) as white solid. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.54 (d, J=8.8 Hz, 4H), 7.42 (t, J=7.6 Hz,

2H), 7.32 (t, J=7.2 Hz, 1H), 7.00 (d J=8.8 Hz, 2H) 4.37 (q, J=8.1 Hz, 2H)
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13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 156.9, 140.3, 135.7, 128.8, 128.4,

127.1, 126.8, 123.4 (q, J=178.1 Hz), 115.2, 65.9 (q, J=35.6 Hz)
Compound 81:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 54% (51.4 mg) as yellow oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.11 (d, J=8.2 Hz, 2H), 6.83 (d, J=8.6 Hz,

2H), 4.30 (q, J=8.2 Hz, 2H), 2.30 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 155.4, 132.0, 130.2, 123.5 (q,

J=278.1 Hz), 114.9, 66.1 (q, J=35.4 Hz), 20.5
Compound 82:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 57% (53.9 mg) as a clear oil.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.86 (t, J=7.9 Hz, 1H), 6.86 (d, J=7.5 Hz,

1H) 6.77-6.72 (m, 2), 4.32 (q, J=8.2 Hz)
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13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 157.4, 140.0, 129.5, 123.4 (q, J=178

Hz), 123.3, 115.8, 111.7, 65.8 (q, J=35.6 Hz), 21.4
19F {1H} NMR

(101 MHz, CDCl3) δ (ppm), -74.0 (t, J=8.2 Hz)

Compound 83:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 71% (67.6 mg) as a clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.164 (t, J=7.6 Hz, 2H), 6.96 (t, J=7.2 Hz,

1H), 6.78 (d, J=8.0 Hz, 1H), 4.34 (q, J=8.1 Hz, 2H), 2.26 (s, 3H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 155.6, 131.2, 127.6, 126.9, 123.2 (q,

J=256.6 Hz), 122.3, 111.8, 66.2 (q, J=35.5 Hz), 15.9
Compound 84:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 87% (78.4 mg) as a clear oil. Spectral data is consistent with
that of previously reported.
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1H

NMR (400 MHz, CDCl3) δ (ppm), 8.18 (d, J=9.2 Hz, 2H), 6.92 (d, J=9.2 Hz,

2H), 4.63 (sept, J=6.0 Hz, 1H) 1.39 (d, J=6.1 hZ, 6H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 163.2, 141.0, 126.0, 115.2, 71.0, 21.8

Compound 85:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 83% (66.9 mg) as an off-white solid. Spectral data is
consistent with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.56 (d, J=8.7 Hz, 2H), 6.91 (d, J=8.7 hz,

2H), 4.62 (setp, J=6.0 Hz, 1H), 1.36 (d, J=6.1 Hz, 6H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 161.4, 134.0, 119.4, 116.0, 103.3,

70.4, 21.8
Compound 86:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 80% (87.2 mg) as a. Spectral data is consistent with that of
previously reported.
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1H

NMR (400 MHz, CDCl3) δ (ppm), 7.51 (d, J=8.7 Hz, 2H), 6.92 (d, J=8.7 Hz,

2H), 4.34 (sext, J=6.1 Hz, 1H), 1.80-1.58 (m, 2H), 1.30 (d, J=6.1 Hz, 3H), 0.97 (t,
J=7.5 Hz, 3H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 160.9, 129.1, 126.9 (q, J=3.8 Hz),

122.4 (q, J=32.6 Hz), 115.5, 75.3, 29.1, 19.1, 9.7
Compound 87:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 70% (80.5 mg) as a white solid. Spectral data is consistent
with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 8.19, (d, J=9.2 Hz, 2H), 7.43-7.36 (m, 5H),

7.02, (d, J=9.2 Hz, 2H), 5.15 (s, 2H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 163.7, 141.6, 135.5, 128.8, 128.5,

127.5, 125.9, 114.8, 70.7
Compound 88:
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Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 70% (64.2 mg) as white solid. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.42 (d, J=7.3 Hz, 2H), 7.36 (t, J=7.3 Hz,

2H), 7.32-7,25 (m, 3H) 6.98-6.93 (m, 3H), 5.03 (s, 2H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 158.8, 137.0, 129.5, 128.5, 127.9,

127.4, 120.9, 114.8, 69.8
Compound 89:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 75% (82.3 mg) as white solid. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.42-7.32 (m, 5H), 7.11 (d, J=9.0 Hz, 2H),

6.88 (d, J=9.0 Hz, 2H), 5.02 (s, 2H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 157.4, 136.6, 129.4, 128.7, 128.1,

127.5, 125.8, 116.2, 70.3
Compound 90:
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Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 63% (62.5 mg) as yellow oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.42 (d, J=7,2 Hz, 2H), 7.36 (t, J=7.31 Hz,

2H), 7.30 (t, J=7.1 H, 1H) 7.07 (d, J=8.3 Hz, 2H), 6.87 (d, J=8.6 Hz, 2H), 5.02 (s,
2H), 2.28 (s, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 156.7, 137.3, 130.2, 130.0, 128.6,

127.9, 127.5, 114.8, 70.1, 20.5
Compound 91:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 63% (63.5 mg) as a clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.29 (d, J=7.3 Hz, 2H), 7.37 (t, J=7.3 Hz,

2H), 7.31 (t, J=7.2 Hz, 1H) 7.11-6.87 (m, 4H), 5.13 (s, 2H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 153.0 (d, J=245.8 Hz), 146.7 (d,

J=10.4 Hz), 136.6, 128.6, 128.1, 127.4, 124.2 (d, J=3.8 Hz), 121.5 (d, J=7.1 Hz),
116.3 (d, J=18.2 Hz), 115.8 (d, J=1.4 Hz), 71.3
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Compound 92:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 71% (71.9 mg) as white solid. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.43-7.31 (m, 5H), 7.24-7.18 (m, 1H), 6.75

(dd, J1=8.3 Hz, J2=2.1 Hz, 1H), 6.71-6.36 (m, 2H), 5.3 (s, 2H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 163.6 (d, J=245.1 Hz), 160.1 (d,

J=10.9 Hz), 136.5, 130.2 (d, J=9.9 Hz), 128.6, 128.1, 127.5, 110.6 (d, J=2.9 Hz),
107.7 (d, J=21.3 Hz), 102.6 (d, J=24.8 Hz), 70.2
Compound 93:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
a 19:1 mixture of regioisomers of 79% yield (70.3 mg) as yellow oil. Spectral data
is consistent with that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.05 (d, J=8.2 Hz, 2H), 6.78 (d, J=8.6 Hz,

2H), 3.91 (t, J=6.6 Hz, 2H), 2.27 (s, 3H), 1.80-1.73 (m, 2H), 1.47-1.33 (m, 4H),
0.92 (t, J=7.1 Hz, 3H)
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13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 157.06, 129.9, 129.6, 114.4, 68.1,

29.1, 28.3, 22.5, 20.5, 14.1
Compound 94:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 93% (109.5 mg) as yellow oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.96 (d, J=8.9 Hz, 2H), 6.89 (d, J=8.9 Hz,

2H), 4.33 (sept, J=4.2 Hz, 1H), 3.87 (s, 3H), 1.99-1.96 (m, 2H), 1.81-1.78 (m,
2H), 1.58-1.53 (m, 3H), 1.43-1.26 (m, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 166.9, 181.8, 131.6, 122.1, 115.1,

75.3, 51.8, 31.6, 30.9, 25.5, 23.6
Compound 95:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 98% (102.8 mg) as yellow oil. Spectral data is consistent with
that of previously reported.
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1H

NMR (400 MHz, CDCl3) δ (ppm), 8.17 (d, J=9.3 Hz, 2H), 6.94 (d, J=9.3 Hz,

2H), 4.04 (t, J=6.6 Hz, 2H), 1.82 (p, J=7.0 Hz, 2H), 1.49-1.34 (m, 4H), 0.94 (T,
J=7.1 Hz, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 164.3, 141.2, 125.8, 114.4, 68.9,

28.7, 28.0, 22.4, 14.0
Compound 96:

Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 72% (83.7 mg) as yellow oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.52 (d, J=8.6 Hz, 2H), 6.92 (d. J=8.6 Hz,

2H), 3.97 (t, J=6.6 Hz, 2H), 1.80 (p, J=7.0 Hz, 2H), 1.48-1.37 (m, 4H), 0.93 (t,
J=7.1 Hz, 3H)
13C {1H}

NMR (101 MHz, CDCl3) δ (ppm), 161.6, 126.8, (q, J=2.8 Hz), 125.9,

123.2, 122.6 (1, J=32.6 Hz), 119.1, 114.4, 68.2, 28.8, 28.1, 22.4, 14.0
Compound 97:
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Synthesized according to the general procedure D on 0.5 mmol scale and obtained
an isolated yield of 91% (94.8 mg) as clear oil. Spectral data is consistent with
that of previously reported.
1H

NMR (400 MHz, CDCl3) δ (ppm), 7.98 (d, J=8.8 Hz, 2H), 6.89 (d, J=8.8 Hz,

2H), 3.99 (t, J=6.5 Hz, 2H), 3.87 (s, 3H), 1.77 (p, J-9.4 Hz, 2H), 1.54-1.44 (m,
2H), 0.97 (t, J=7.4 Hz, 3H)
13C

{1H} NMR (101 MHz, CDCl3) δ (ppm), 166.9, 163.0, 131.6, 122.3, 114.1,

67.9, 51.8, 31.2, 19.2, 13.8
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S.3.1 1H, 13C{1H}, 19F{1H} NMR Spectra of Alkyl-Aryl Ether Synthesis

Figure 163. 1H NMR of compound 78 at 400 MHz in CDCl3 at 298 K

Figure 164. 13C{1H} NMR of compound 78 at 101 MHz in CDCl3 at 298 K
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Figure 165. 1H NMR of compound 79 at 400 MHz in CDCl3 at 298 K

Figure 166. 13C{1H} NMR of compound 79 at 101 MHz in CDCl3 at 298 K
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Figure 167. 1H NMR of compound 80 at 400 MHz in CDCl3 at 298 K

Figure 168. 13C{1H} NMR of compound 80 at 101 MHz in CDCl3 at 298 K
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Figure 169. 1H NMR of compound 81 at 400 MHz in CDCl3 at 298 K

Figure 170. 13C{1H} NMR of compound 81 at 101 MHz in CDCl3 at 298 K
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Figure 171. 1H NMR of compound 82 at 400 MHz in CDCl3 at 298 K

Figure 172. 13C{1H} NMR of compound 82 at 101 MHz in CDCl3 at 298 K
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Figure 173. 19F {1H} NMR of compound 82 at 400 MHz in CDCl3 at 298 K
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Figure 174. 1H NMR of compound 83 at 400 MHz in CDCl3 at 298 K

Figure 175. 13C{1H} NMR of compound 83 at 101 MHz in CDCl3 at 298 K

222

Figure 176. 1H NMR of compound 84 at 400 MHz in CDCl3 at 298 K

Figure 177. 13C{1H} NMR of compound 84 at 101 MHz in CDCl3 at 298 K
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Figure 178. 1H NMR of compound 85 at 400 MHz in CDCl3 at 298 K

Figure 179. 13C{1H} NMR of compound 85 at 101 MHz in CDCl3 at 298 K
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Figure 180. 1H NMR of compound 86 at 400 MHz in CDCl3 at 298 K

Figure 181. 13C{1H} NMR of compound 86 at 101 MHz in CDCl3 at 298 K
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Figure 182. 1H NMR of compound 87 at 400 MHz in CDCl3 at 298 K

Figure 183. 13C{1H} NMR of compound 87 at 101 MHz in CDCl3 at 298 K
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Figure 184. 1H NMR of compound 88 at 400 MHz in CDCl3 at 298 K

Figure 185. 13C{1H} NMR of compound 88 at 101 MHz in CDCl3 at 298 K
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Figure 186. 1H NMR of compound 89 at 400 MHz in CDCl3 at 298 K

Figure 187. 13C{1H} NMR of compound 89 at 101 MHz in CDCl3 at 298 K
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Figure 188. 1H NMR of compound 90 at 400 MHz in CDCl3 at 298 K
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Figure 189. 13C{1H} NMR of compound 90 at 101 MHz in CDCl3 at 298 K

229

O

Ph

F

Figure 190. 1H NMR of compound 91 at 400 MHz in CDCl3 at 298 K
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Figure 191. 13C{1H} NMR of compound 91 at 101 MHz in CDCl3 at 298 K
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Figure 192. 1H NMR of compound 92 at 400 MHz in CDCl3 at 298 K
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Figure 193. 13C{1H} NMR of compound 92 at 101 MHz in CDCl3 at 298 K
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Figure 194. 1H NMR of compound 93 at 400 MHz in CDCl3 at 298 K

Figure 195. 13C{1H} NMR of compound 93 at 101 MHz in CDCl3 at 298 K
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Figure 196. 1H NMR of compound 94 at 400 MHz in CDCl3 at 298 K

Figure 197. 13C{1H} NMR of compound 94 at 101 MHz in CDCl3 at 298 K
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Figure 198. 1H NMR of compound 95 at 400 MHz in CDCl3 at 298 K

Figure 199. 13C{1H} NMR of compound 95 at 101 MHz in CDCl3 at 298 K
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Figure 200. 1H NMR of compound 96 at 400 MHz in CDCl3 at 298 K

O
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Figure 201. 13C{1H} NMR of compound 96 at 101 MHz in CDCl3 at 298 K
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Figure 202. 1H NMR of compound 97 at 400 MHz in CDCl3 at 298 K

Figure 203. 13C{1H} NMR of compound 97 at 101 MHz in CDCl3 at 298 K
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Appendix G. General Procedure for Anion Exchange via Solid-Phase
Column.
General Procedure E: The column, of appropriate sodium salt, is construct as
shown in Figure 1 and described in the accompanying text. Aryl(TMP)iodonium
tosylate (2 mmol) is weighed out, transferred to an Erlenmeyer flask, and
dissolved in DCM (20 mL). The aryl(TMP)iodonium tosylate solution is poured
onto the column and eluted by gravity. An additional 80 mL of DCM is passed
through the column to wash any remaining iodonium salt off the column. The
bulk of the DCM is removed under reduced pressure on a rotary evaporator to
yield an oily residue.

The residue is triturated with tert-butyl methyl ether

(TBME; 250 mL) to precipitate the iodonium salt product. The solid product is
isolated by filtration and washed with additional TBME (20 mL).
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S.4 Diaryliodonium Counter Anion Metathesis
S.4.1 Scope of Diaryliodonium Counter Anion Metathesis via Solid Phase
Column
Compound 98:

Synthesized according to the general procedure E on 2 mmol scale with 250
mmol of NaTFA admixed with sand (20 g). The product was obtained as a white
powder in 73% yield (0.797 g). The spectral data was consistent with that
previously described.
1H

NMR (400 MHz, DMSO-d6) δ 8.12 – 7.72 (m, 4H), 6.18 (s, 2H), 3.90 (s, 3H),

3.87 (s, 6H), 3.86 (s, 3H)
13C{1H}

NMR (101 MHz, DMSO-d6) δ 167.0, 165.7, 161.4 (q, J=34.0 Hz),

160.50, 133.7, 132.5, 132.0, 121.5, 116.6 (q, J=295.2 Hz), 91.6, 86.0, 56.9, 56.0,
52.6
19F{1H}

NMR (376 MHz, DMSO-d6) δ -75.24.

Compound 99:
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Synthesized according to the general procedure E on 2 mmol scale with 250
mmol of NaTFA admixed with sand (20 g). The product was observed as a white
powder in 83% yield (0.898 g). Spectral data was consistent with that previously
described.
1H

NMR (400 MHz, DMSO-d6) δ 7.84 (d, J=8.6 Hz, 2H), 7.49 (d, J=8.7 Hz,

2H), 6.47 (s, 2H), 3.96 (s, 6H), 3.87 (s, 3H), 1.25 (s, 9H).
13C{1H}

NMR (101 MHz, DMSO-d6) δ 166.0, 159.4, 157.7 (q, J=30.4 Hz), 154.5,

134.1, 128.6, 117.3 (q, J=301.1 Hz), 112.8, 92.0, 87.2, 57.3, 56.1, 34.8 30.7.
19F{1H}

NMR (376 MHz, DMSO-d6) δ -73.41.

Compound 100:

Synthesized according to the general procedure E on 2 mmol scale with 250
mmol of NaTFA admixed with sand (20 g). The product was obtained as a white
powder in 84% yield (0.940 g). Spectral data was consistent with that previously
reported.
1H

NMR (400 MHz, DMSO-d6) δ 7.99 (d, J=7.7 Hz, 2H), 7.75 (d, J=7.7 Hz, 2H),

7.67 (d, J=7.6 Hz, 2H), 7.49 (t, J=7.2 Hz, 2H), 7.42 (t, J=7.4 Hz, 1H), 6.49 (s,
2H), 3.98 (s, 6H), 3.88 (s, 3H).
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13C{1H}

NMR (101 MHz, DMSO-d6) δ 166.6, 159.9, 158.3 (q, J=30.5 Hz), 143.6,

138.7, 135.3, 130.1, 129.6, 129.0, 127.4, 117.8 (q, J=301.1 Hz), 115.3, 92.5, 87.8,
57.8 56.6.
19F{1H}

NMR (376 MHz, DMSO-d6) δ -73.40.

Compound 101:

Synthesized according to the general procedure E on 1 mmol scale and 250 mmol
of NaTFA admixed with sand (20 g). The eluent used was 95:5 DCM : MeOH.
The product was obtained as a white solid in 75% yield (0.390 g). Spectral data
was consistent with that previously reported.
1H

NMR (400 MHz, DMSO-d6) δ 8.86 (d, J=2.1 Hz, 1H), 8.37 (dd, J=8.5, 2.3 Hz,

1H), 7.63 (d, J=8.5 Hz, 1H), 6.46 (s, 2H), 3.95 (s, 6H), 3.87 (s, 3H).
13C{1H}

NMR (101 MHz, DMSO-d6) δ 166.7, 159.7, 158.5 (q, J=30.9 Hz), 154.0,

153.1, 145.5, 127.9, 117.6 (q, J=300.4 Hz), 114.7, 92.5, 88.2, 57.8, 56.6.
19F{1H}

NMR (376 MHz, DMSO-d6) δ -73.50.

Compound 102:
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Synthesized according to the general procedure E on 2 mmol scale with 250
mmol of NaBr. The product was obtained as a white powder in 90% yield (0.920
g).
1H

NMR (400 MHz, DMSO-d6) δ 8.10 – 7.98 (m, 2H), 7.92 – 7.87 (m, 2H), 6.15

(s, 2H), 3.89 (s, 3H), 3.88 (s, 6H), 3.84 (s, 3H).
13C{1H}

NMR (101 MHz, DMSO-d6) δ 206.4, 165.8, 165.2, 159.3, 134.4, 131.5

(d, J=17.3 Hz), 123.5, 92.0, 90.5, 64.9, 57.2, 56.0, 52.5, 48.5, 30.6, 15.1.
FTIR: 3077, 2846, 2841, 1724, 1578, 1451, 1340, 1281, 1188, 814 cm -1.
HRMS: (ESI+) Calculated for C17H18IO5+ [M – Br]+, 429.01934; observed
429.01966.
Melting Point: 157-158 °C
Compound 103:

Synthesized according to the general procedure E on 2 mmol scale of with 300
mmol NaBr. The product was obtained as a white powder in 96% yield (0.973 g).
1H

NMR (400 MHz, DMSO-d6) δ 7.86 – 7.78 (m, 2H), 7.50 – 7.41 (m, 2H), 6.44

(s, 2H), 3.94 (s, 6H), 3.86 (s, 3H), 1.24 (s, 9H).
13C{1H}

NMR (101 MHz, DMSO-d6) δ 206.4, 165.8, 165.22, 159.3, 134.4, 131.6,

131.4, 123.5, 92.0, 90.5, 64.9, 57.2, 56.0, 52.5, 48.5, 30.6, 15.1.
FTIR: 3077, 2846, 2841, 1724, 1578, 1451, 1340, 1281, 1188, 814 cm -1.
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HRMS: (ESI+) Calculated for C17H18IO5+ [M – Br]+, 429.01934; observed
429.01966.
Melting Point: 157.5-157.9 °C.
Compound 104:

Synthesized according to the general procedure E on 2 mmol scale and 450 mmol
of NaBr. The product was obtained as a white powder in 88% yield (0.931 g).
The spectral data was consistent with that previously reported.
1H

NMR (400 MHz, DMSO-d6) δ 7.98(d, J=8.2 Hz, 2H), 7.72(d, J=8.3 HZ, 2H)

7.66(d, J=7.7Hz, 2H), 7.49(t, J=7.5Hz, 2H), 7.42(t, J=7.2Hz, 1H) 6.46(s, 2H)
3.96(s, 6H), 3.87(s, 3H).
13C{1H}

NMR (101 MHz, DMSO-d6) δ 166.3, 159.8, 143.3, 138.8, 135.2, 129.9,

129.6, 129.0, 127.4, 116.6, 92.5, 89.9, 57.8, 56.6
Compound 105:

Synthesized according to the general procedure E on 2 mmol scale of and 400
mmol of NaBr. The eluent used was 95:5 DCM: MeOH. The product was
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obtained as a white powder in 88% yield (0.855 g). Spectral data was consistent
with that previously reported.
1H

NMR (400 MHz, DMSO) δ 8.84 (d, J=2.0 Hz, 1H), 8.36 (dd, J=8.5, 2.4 Hz,

1H), 7.60 (d, J=8.5 Hz, 1H), 6.45 (s, 2H), 3.97 (s, 7H), 3.89 (s, 3H).
13C{1H}

NMR (101 MHz, DMSO) δ 166.2, 159.6, 153.7, 152.4, 145.3, 127.6,

116.4, 92.4, 92.3, 57.7, 56.6.
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S.4.2 1H, 13C{1H}, 19F{1H} NMR Spectra of Scope of Diaryliodonium Counter
Anion Metathesis via Solid Phase Column

Figure 204. 1H NMR of compound 101 at 400 MHz in DMSO-d6 at 298 K

Figure 205. 13C{1H} NMR of compound 98 at 101 MHz in DMSO-d6 at 298 K.
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Figure 206. 1H NMR of compound 99 at 400 MHz in DMSO-d6 at 298 K.

Figure 207. 13C{1H} NMR of compound 99 at 101 MHz in DMSO-d6 at 298 K.
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Figure 208. 1H NMR of compound 100 at 400 MHz in DMSO-d6 at 298 K.

Figure 209. 13C{1H} NMR of compound 100 at 101 MHz in DMSO-d6 at 298 K.
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Figure 210. 1H NMR of compound 101 at 400 MHz in DMSO-d6 at 298 K.

Figure 211. 13C{1H} NMR of compound 101at 101 MHz in DMSO-d6 at 298 K.
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Figure 212. 1H NMR of compound 102 at 400 MHz in DMSO-d6 at 298 K.

Figure 213. 13C{1H} NMR of compound 102 at 101 MHz in DMSO-d6 at 298 K.
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Figure 214. 1H NMR of compound 103 at 400 MHz in DMSO-d6 at 298 K.

Figure 215. 13C{1H} NMR of compound 103 at 101 MHz in DMSO-d6 at 298 K.
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Figure 216. 1H NMR of compound 104 at 400 MHz in DMSO-d6 at 298 K.

Figure 217. 13C{1H} NMR of compound 104 at 101 MHz in DMSO-d6 at 298 K.
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Figure 218. 1H NMR of compound 105 at 400 MHz in DMSO-d6 at 298 K.

Figure 219. 13C{1H} NMR of compound 105 at 101 MHz in DMSO-d6 at 298 K.
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S.5 Example Order Placed Through Otava Chemicals
All diaryliodonium salts prepared using literature conditions. 73 1H Quantitative
NMR analysis was ran using 4,4’-dihydroxybiphenyl internal standard.
S.5.1 1H Quantitative NMR Analysis for Example Order Placed Through
Otava Chemicals

Figure 220. 1H Quantitative NMR analysis of compound 106
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Figure 221. 1H Quantitative NMR analysis of compound 107

Figure 222. 1H Quantitative NMR analysis of compound 108
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Figure 223. 1H Quantitative NMR analysis of compound 109

Figure 224. 1H Quantitative NMR analysis of compound 110
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Figure 225. 1H Quantitative NMR analysis of compound 111

Figure 226. 1H Quantitative NMR analysis of compound 112

255

Figure 227. 1H Quantitative NMR analysis of compound 113

Figure 228. 1H Quantitative NMR analysis of compound 114

256

Figure 229. 1H Quantitative NMR analysis of compound 115
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